Michel Hamon - Publications

Affiliations: 
INSERM, Rennes, Bretagne, France 

363/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sevoz-Couche C, Machado BH, Hamon M, Laguzzi R. The Key Role of Medullary 5-HT3 Receptors in the Serotonin-Mediated Neural Control of Cardiovascular Function. Current Neuropharmacology. 3: 231-248. PMID 32550629 DOI: 10.2174/1570159054368277  0.332
2020 Martin V, Mathieu L, Diaz J, Salman H, Alterio J, Chevarin C, Lanfumey L, Hamon M, Austin MC, Darmon M, Stockmeier CA, Masson J. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment. Journal of Psychiatry & Neuroscience : Jpn. 45: 190134. PMID 32459080 DOI: 10.1503/Jpn.190134  0.637
2018 M'Dahoma S, Poitevin M, Dabala E, Payan H, Gabriel C, Mocaër E, Bourgoin S, Hamon M. α- and β-Adrenoreceptor-Mediated Efficacy of the Atypical Antidepressant Agomelatine Combined With Gabapentin to Suppress Allodynia in Neuropathic Rats With Ligated Infraorbital or Sciatic Nerve. Frontiers in Pharmacology. 9: 587. PMID 29930510 DOI: 10.3389/fphar.2018.00587  0.408
2016 Gautier A, El Ouaraki H, Bazin N, Salam S, Vodjdani G, Bourgoin S, Pezet S, Bernard JF, Hamon M. Lentiviral vector-driven inhibition of 5-HT synthesis in B3 bulbo-spinal serotonergic projections - Consequences on nociception, inflammatory and neuropathic pain in rats. Experimental Neurology. PMID 27983993 DOI: 10.1016/j.expneurol.2016.10.016  0.319
2016 Jeanson T, Duchêne A, Richard D, Bourgoin S, Picoli C, Ezan P, Mouthon F, Giaume C, Hamon M, Charvériat M. Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats. Scientific Reports. 6: 38766. PMID 27941941 DOI: 10.1038/srep38766  0.301
2015 M'Dahoma S, Barthélemy S, Tromilin C, Jeanson T, Viguier F, Michot B, Pezet S, Hamon M, Bourgoin S. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26343858 DOI: 10.1016/j.euroneuro.2015.07.026  0.332
2015 Kayser V, Viguier F, Melfort M, Bourgoin S, Hamon M, Masson J. Altered nociception in mice with genetically induced hypoglutamatergic tone. Neuroscience. 293: 80-91. PMID 25743253 DOI: 10.1016/j.neuroscience.2015.02.044  0.304
2015 Michot B, Kayser V, Hamon M, Bourgoin S. CGRP receptor blockade by MK-8825 alleviates allodynia in infraorbital nerve-ligated rats. European Journal of Pain (London, England). 19: 281-90. PMID 25370954 DOI: 10.1002/ejp.616  0.303
2015 Abid S, Boiron E, Tissot C, Houssaini A, Czibik G, Sawaki D, Marcos E, Wan F, Dubois-Randé J, Hamon M, Derumeaux G, Adnot S. The role of 5-HT2B receptors in development of valvulopathy, cardiomyopathy, and pulmonary hypertension in Fawn-Hooded rats Revue Des Maladies Respiratoires. 32: 328. DOI: 10.1016/j.rmr.2015.02.059  0.325
2014 Thibault K, Lin WK, Rancillac A, Fan M, Snollaerts T, Sordoillet V, Hamon M, Smith GM, Lenkei Z, Pezet S. BDNF-dependent plasticity induced by peripheral inflammation in the primary sensory and the cingulate cortex triggers cold allodynia and reveals a major role for endogenous BDNF as a tuner of the affective aspect of pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14739-51. PMID 25355226 DOI: 10.1523/Jneurosci.0860-14.2014  0.306
2014 M'Dahoma S, Bourgoin S, Kayser V, Barthélémy S, Chevarin C, Chali F, Orsal D, Hamon M. Spinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterization. Plos One. 9: e102027. PMID 25019623 DOI: 10.1371/journal.pone.0102027  0.312
2014 Martin CB, Hamon M, Lanfumey L, Mongeau R. Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs. Neuroscience and Biobehavioral Reviews. 42: 208-23. PMID 24631644 DOI: 10.1016/j.neubiorev.2014.03.001  0.381
2014 Bouaziz E, Emerit MB, Vodjdani G, Gautheron V, Hamon M, Darmon M, Masson J. Neuronal phenotype dependency of agonist-induced internalization of the 5-HT(1A) serotonin receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 282-94. PMID 24381289 DOI: 10.1523/JNEUROSCI.0186-13.2014  0.636
2014 Michot B, Kayser V, Bastian G, Bourgoin S, Hamon M. Differential pharmacological alleviation of oxaliplatin-induced hyperalgesia/allodynia at cephalic versus extra-cephalic level in rodents. Neuropharmacology. 79: 432-43. PMID 24361454 DOI: 10.1016/j.neuropharm.2013.12.011  0.325
2013 Hamon M, Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 45: 54-63. PMID 23602950 DOI: 10.1016/J.Pnpbp.2013.04.009  0.42
2013 Meunier CN, Amar M, Lanfumey L, Hamon M, Fossier P. 5-HT(1A) receptors direct the orientation of plasticity in layer 5 pyramidal neurons of the mouse prefrontal cortex. Neuropharmacology. 71: 37-45. PMID 23523560 DOI: 10.1016/J.Neuropharm.2013.03.003  0.421
2013 Viguier F, Michot B, Hamon M, Bourgoin S. Multiple roles of serotonin in pain control mechanisms--implications of 5-HT₇ and other 5-HT receptor types. European Journal of Pharmacology. 716: 8-16. PMID 23500207 DOI: 10.1016/j.ejphar.2013.01.074  0.475
2013 Martin CB, Ramond F, Farrington DT, Aguiar AS, Chevarin C, Berthiau AS, Caussanel S, Lanfumey L, Herrick-Davis K, Hamon M, Madjar JJ, Mongeau R. RNA splicing and editing modulation of 5-HT(2C) receptor function: relevance to anxiety and aggression in VGV mice. Molecular Psychiatry. 18: 656-65. PMID 23247076 DOI: 10.1038/mp.2012.171  0.373
2013 Gau R, Sévoz-Couche C, Hamon M, Bernard JF. Noxious stimulation excites serotonergic neurons: a comparison between the lateral paragigantocellular reticular and the raphe magnus nuclei. Pain. 154: 647-59. PMID 23142143 DOI: 10.1016/J.Pain.2012.09.012  0.309
2012 Al Awabdh S, Miserey-Lenkei S, Bouceba T, Masson J, Kano F, Marinach-Patrice C, Hamon M, Emerit MB, Darmon M. A new vesicular scaffolding complex mediates the G-protein-coupled 5-HT1A receptor targeting to neuronal dendrites. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 14227-41. PMID 23055492 DOI: 10.1523/JNEUROSCI.6329-11.2012  0.806
2012 Gutknecht L, Araragi N, Merker S, Waider J, Sommerlandt FM, Mlinar B, Baccini G, Mayer U, Proft F, Hamon M, Schmitt AG, Corradetti R, Lanfumey L, Lesch KP. Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification. Plos One. 7: e43157. PMID 22912815 DOI: 10.1371/journal.pone.0043157  0.324
2012 Viguier F, Michot B, Kayser V, Bernard JF, Vela JM, Hamon M, Bourgoin S. GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain. Neuropharmacology. 63: 1093-106. PMID 22820553 DOI: 10.1016/j.neuropharm.2012.07.023  0.437
2012 Abid S, Houssaini A, Chevarin C, Marcos E, Tissot CM, Gary-Bobo G, Wan F, Mouraret N, Amsellem V, Dubois-Randé JL, Hamon M, Adnot S. Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 303: L500-8. PMID 22797248 DOI: 10.1152/ajplung.00049.2012  0.37
2012 Michot B, Bourgoin S, Viguier F, Hamon M, Kayser V. Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat. Pain. 153: 1939-48. PMID 22795918 DOI: 10.1016/j.pain.2012.06.009  0.365
2012 Brenchat A, Rocasalbas M, Zamanillo D, Hamon M, Vela JM, Romero L. Assessment of 5-HT(7) Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versus Wild-Type Mice. Advances in Pharmacological Sciences. 2012: 312041. PMID 22761612 DOI: 10.1155/2012/312041  0.445
2012 Boulle F, Kenis G, Cazorla M, Hamon M, Steinbusch HW, Lanfumey L, van den Hove DL. TrkB inhibition as a therapeutic target for CNS-related disorders. Progress in Neurobiology. 98: 197-206. PMID 22705453 DOI: 10.1016/J.Pneurobio.2012.06.002  0.322
2012 Constandil L, Goich M, Hernández A, Bourgeais L, Cazorla M, Hamon M, Villanueva L, Pelissier T. Cyclotraxin-B, a new TrkB antagonist, and glial blockade by propentofylline, equally prevent and reverse cold allodynia induced by BDNF or partial infraorbital nerve constriction in mice. The Journal of Pain : Official Journal of the American Pain Society. 13: 579-89. PMID 22560237 DOI: 10.1016/J.Jpain.2012.03.008  0.337
2012 Fournet V, Schweitzer A, Chevarin C, Deloulme JC, Hamon M, Giros B, Andrieux A, Martres MP. The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances. Journal of Neurochemistry. 121: 99-114. PMID 22146001 DOI: 10.1111/J.1471-4159.2011.07615.X  0.579
2012 Brenchat A, Zamanillo D, Hamon M, Romero L, Vela JM. Role of peripheral versus spinal 5-HT(7) receptors in the modulation of pain undersensitizing conditions. European Journal of Pain (London, England). 16: 72-81. PMID 21843960 DOI: 10.1016/j.ejpain.2011.07.004  0.451
2012 Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Molecular Psychiatry. 17: 926-39. PMID 21769100 DOI: 10.1038/Mp.2011.87  0.617
2012 Masson J, Bouaziz E, Emerit M, Hamon M, Darmon M. S.11.02 Brain region-dependent internalisation of 5-HT1A receptors: molecular mechanisms and relevance for antidepressant therapy European Neuropsychopharmacology. 22: S128. DOI: 10.1016/S0924-977X(12)70153-0  0.552
2012 Martin C, Chevarin C, Gassman M, Hamon M, Bettler B, Lanfumey L, Mongeau R. GABAergic control of central serotonergic neurotransmission – role of GABAB receptors and possible implication in the antidepressant action of ketamine L'EncéPhale. 38: S5. DOI: 10.1016/J.Encep.2012.06.027  0.375
2012 Masson J, Emerit MB, Hamon M, Darmon M. Serotonergic signaling: Multiple effectors and pleiotropic effects Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 1: 685-713. DOI: 10.1002/wmts.50  0.459
2011 Narboux-Nême N, Sagné C, Doly S, Diaz SL, Martin CB, Angenard G, Martres MP, Giros B, Hamon M, Lanfumey L, Gaspar P, Mongeau R. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2538-50. PMID 21814181 DOI: 10.1038/Npp.2011.142  0.638
2011 Carrel D, Simon A, Emerit MB, Rivals I, Leterrier C, Biard M, Hamon M, Darmon M, Lenkei Z. Axonal targeting of the 5-HT1B serotonin receptor relies on structure-specific constitutive activation. Traffic (Copenhagen, Denmark). 12: 1501-20. PMID 21801291 DOI: 10.1111/J.1600-0854.2011.01260.X  0.626
2011 Jahanshahi A, Le Maitre E, Temel Y, Lanfumey L, Hamon M, Lesch KP, Tordera RM, Del Río J, Aso E, Maldonado R, Hökfelt T, Steinbusch HW. Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety. Journal of Chemical Neuroanatomy. 41: 227-33. PMID 21704153 DOI: 10.1016/j.jchemneu.2011.05.015  0.42
2011 Netzer F, Bernard JF, Verberne AJ, Hamon M, Camus F, Benoliel JJ, Sévoz-Couche C. Brain circuits mediating baroreflex bradycardia inhibition in rats: an anatomical and functional link between the cuneiform nucleus and the periaqueductal grey. The Journal of Physiology. 589: 2079-91. PMID 21486808 DOI: 10.1113/jphysiol.2010.203737  0.33
2011 Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol JC, Lu L, Alvarez-Fischer D, Carrillo-de Sauvage MA, Saurini F, Coussieu C, Kinugawa K, Prigent A, Höglinger G, Hamon M, Tronche F, et al. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 108: 6632-7. PMID 21467220 DOI: 10.1073/pnas.1017820108  0.307
2011 Hoyle D, Juhasz G, Aso E, Chase D, del Rio J, Fabre V, Hamon M, Lanfumey L, Lesch KP, Maldonado R, Serra MA, Sharp T, Tordera R, Toro C, Deakin JF. Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 3-10. PMID 21030216 DOI: 10.1016/j.euroneuro.2010.09.011  0.341
2011 Kayser V, Latrémolière A, Hamon M, Bourgoin S. N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain. European Journal of Pain (London, England). 15: 451-8. PMID 20965753 DOI: 10.1016/j.ejpain.2010.09.012  0.4
2011 Bouaziz E, Emerit M, Hamon M, Darmon M, Masson J. P.1.021 Serotoninergic 5-HT1A receptor internalisation and trafficking in cell lines and neurons: a role in desensitisation? European Neuropsychopharmacology. 21: S19. DOI: 10.1016/S0924-977X(11)70022-0  0.577
2011 Al Awabdh S, Emerit M, Masson J, Hamon M, Darmon M. P.1.016 Control of the dendritic targeting of the 5-HT1A serotonin receptor as an alternative antidepressant therapy European Neuropsychopharmacology. 21: S15. DOI: 10.1016/S0924-977X(11)70017-7  0.581
2010 Fournet V, Jany M, Fabre V, Chali F, Orsal D, Schweitzer A, Andrieux A, Messanvi F, Giros B, Hamon M, Lanfumey L, Deloulme JC, Martres MP. The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. Journal of Neurochemistry. 115: 1579-94. PMID 20969568 DOI: 10.1111/J.1471-4159.2010.07064.X  0.611
2010 Mongeau R, Martin CB, Chevarin C, Maldonado R, Hamon M, Robledo P, Lanfumey L. 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment. Journal of Neurochemistry. 115: 438-49. PMID 20796171 DOI: 10.1111/j.1471-4159.2010.06932.x  0.442
2010 Bonnavion P, Bernard JF, Hamon M, Adrien J, Fabre V. Heterogeneous distribution of the serotonin 5-HT(1A) receptor mRNA in chemically identified neurons of the mouse rostral brainstem: Implications for the role of serotonin in the regulation of wakefulness and REM sleep. The Journal of Comparative Neurology. 518: 2744-70. PMID 20506474 DOI: 10.1002/Cne.22331  0.42
2010 Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM. Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity. Pain. 149: 483-94. PMID 20399562 DOI: 10.1016/j.pain.2010.03.007  0.459
2010 Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, El Mestikawy S. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2198-210. PMID 20147547 DOI: 10.1523/Jneurosci.5196-09.2010  0.747
2010 Kayser V, Viguier F, Ioannidi M, Bernard JF, Latrémolière A, Michot B, Vela JM, Buschmann H, Hamon M, Bourgoin S. Differential anti-neuropathic pain effects of tetrodotoxin in sciatic nerve- versus infraorbital nerve-ligated rats--behavioral, pharmacological and immunohistochemical investigations. Neuropharmacology. 58: 474-87. PMID 19747496 DOI: 10.1016/j.neuropharm.2009.09.003  0.333
2010 Mongeau R, Martin C, Chevarin C, Maldonaldo R, Hamon M, Robledo P, Lanfumey L. S01-04 - 5-HT2C receptor activation inhibits stress-induced increase in 5-HT transmission: relevance to the effects of antidepressant drugs European Psychiatry. 25: 124. DOI: 10.1016/S0924-9338(10)70124-3  0.431
2009 Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15575-85. PMID 20007481 DOI: 10.1523/Jneurosci.3138-09.2009  0.344
2009 Gau R, Sévoz-Couche C, Laguzzi R, Hamon M, Bernard JF. Inhibition of cardiac baroreflex by noxious thermal stimuli: a key role for lateral paragigantocellular serotonergic cells. Pain. 146: 315-24. PMID 19879048 DOI: 10.1016/J.Pain.2009.09.018  0.305
2009 Butini S, Budriesi R, Hamon M, Morelli E, Gemma S, Brindisi M, Borrelli G, Novellino E, Fiorini I, Ioan P, Chiarini A, Cagnotto A, Mennini T, Fracasso C, Caccia S, et al. Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization. Journal of Medicinal Chemistry. 52: 6946-50. PMID 19831400 DOI: 10.1021/Jm901126M  0.4
2009 Netzer F, Mandjee N, Verberne AJ, Bernard JF, Hamon M, Laguzzi R, Sévoz-Couche C. Inhibition of the bradycardic component of the von Bezold-Jarisch reflex and carotid chemoreceptor reflex by periaqueductal gray stimulation: involvement of medullary receptors. The European Journal of Neuroscience. 29: 2017-28. PMID 19453625 DOI: 10.1111/j.1460-9568.2009.06758.x  0.417
2009 Morelli E, Gemma S, Budriesi R, Campiani G, Novellino E, Fattorusso C, Catalanotti B, Coccone SS, Ros S, Borrelli G, Persico M, Fiorini I, Nacci V, Ioan P, Chiarini A, ... Hamon M, et al. Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. Journal of Medicinal Chemistry. 52: 3548-62. PMID 19425598 DOI: 10.1021/Jm900018B  0.418
2009 Aso E, Renoir T, Mengod G, Ledent C, Hamon M, Maldonado R, Lanfumey L, Valverde O. Lack of CB1 receptor activity impairs serotonergic negative feedback. Journal of Neurochemistry. 109: 935-44. PMID 19302195 DOI: 10.1111/j.1471-4159.2009.06025.x  0.474
2009 Kasper S, Hamon M. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 117-26. PMID 19255935 DOI: 10.1080/15622970902717024  0.363
2009 Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM. 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain. 141: 239-47. PMID 19118950 DOI: 10.1016/j.pain.2008.11.009  0.465
2009 Moulin-Sallanon M, Charnay Y, Ginovart N, Perret P, Lanfumey L, Hamon M, Hen R, Fagret D, Ibáñez V, Millet P. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins. Synapse (New York, N.Y.). 63: 106-16. PMID 19016488 DOI: 10.1002/syn.20588  0.45
2009 Viguier F, Michot B, Kayser V, Vela J, Hamon M, Bourgoin S. 253 ANTI-HYPERALGESIC EFFECTS OF 5-HT7 RECEPTOR ACTIVATION IN RATS SUFFERING FROM NEUROPATHIC PAIN: ROLE OF GABAA RECEPTORS European Journal of Pain. 13: S80a-S80. DOI: 10.1016/S1090-3801(09)60256-1  0.433
2009 Michot B, Bourgoin S, Viguier F, Hamon M, Kayser V. 242 CGRP-RECEPTOR BLOCKADE BY BIBN4096BS REDUCES ALLODYNIA, FOS EXPRESSION AND ATF3 UPREGULATION IN A RAT MODEL OF TRIGEMINAL NEUROPATHIC PAIN European Journal of Pain. 13: S77a-S77. DOI: 10.1016/S1090-3801(09)60245-7  0.329
2008 Kelaï S, Renoir T, Chouchana L, Saurini F, Hanoun N, Hamon M, Lanfumey L. Chronic voluntary ethanol intake hypersensitizes 5-HT(1A) autoreceptors in C57BL/6J mice. Journal of Neurochemistry. 107: 1660-70. PMID 19094059 DOI: 10.1111/j.1471-4159.2008.05733.x  0.39
2008 Thibault K, Van Steenwinckel J, Brisorgueil MJ, Fischer J, Hamon M, Calvino B, Conrath M. Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat. Pain. 140: 305-22. PMID 18930597 DOI: 10.1016/j.pain.2008.09.006  0.398
2008 Carrel D, Masson J, Al Awabdh S, Capra CB, Lenkei Z, Hamon M, Emerit MB, Darmon M. Targeting of the 5-HT1A serotonin receptor to neuronal dendrites is mediated by Yif1B. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8063-73. PMID 18685031 DOI: 10.1523/Jneurosci.4487-07.2008  0.81
2008 Renoir T, Païzanis E, El Yacoubi M, Saurini F, Hanoun N, Melfort M, Lesch KP, Hamon M, Lanfumey L. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 1149-62. PMID 18611291 DOI: 10.1017/S1461145708009048  0.432
2008 Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neuroscience and Biobehavioral Reviews. 32: 1174-84. PMID 18534678 DOI: 10.1016/j.neubiorev.2008.04.006  0.383
2008 Benmessaoud D, Hamdani N, Boni C, Ramoz N, Hamon M, Kacha F, Gorwood P. Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics. Bmc Psychiatry. 8: 40. PMID 18513383 DOI: 10.1186/1471-244X-8-40  0.318
2008 Bouvrais-Veret C, Weiss S, Hanoun N, Andrieux A, Schweitzer A, Job D, Hamon M, Giros B, Martres MP. Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. Journal of Neurochemistry. 104: 745-56. PMID 18199119 DOI: 10.1111/J.1471-4159.2007.05025.X  0.57
2008 Bernard JF, Netzer F, Gau R, Hamon M, Laguzzi R, Sévoz-Couche C. Critical role of B3 serotonergic cells in baroreflex inhibition during the defense reaction triggered by dorsal periaqueductal gray stimulation. The Journal of Comparative Neurology. 506: 108-21. PMID 17990274 DOI: 10.1002/Cne.21532  0.384
2008 Van Steenwinckel J, Brisorgueil MJ, Fischer J, Vergé D, Gingrich JA, Bourgoin S, Hamon M, Bernard R, Conrath M. Role of spinal serotonin 5-HT2A receptor in 2',3'-dideoxycytidine-induced neuropathic pain in the rat and the mouse. Pain. 137: 66-80. PMID 17888573 DOI: 10.1016/j.pain.2007.08.014  0.43
2008 Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. The International Journal of Neuropsychopharmacology. 11: 79-92. PMID 17559709 DOI: 10.1017/S1461145707007857  0.41
2007 Izikki M, Hanoun N, Marcos E, Savale L, Barlier-Mur AM, Saurini F, Eddahibi S, Hamon M, Adnot S. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 293: L1045-52. PMID 17675372 DOI: 10.1152/ajplung.00082.2007  0.368
2007 Sahly I, Fabre V, Vyas S, Milet A, Rouzeau JD, Hamon M, Lazar M, Tronche F. 5-HT1A-iCre, a new transgenic mouse line for genetic analyses of the serotonergic pathway. Molecular and Cellular Neurosciences. 36: 27-35. PMID 17656109 DOI: 10.1016/j.mcn.2007.05.005  0.404
2007 Doucet E, Latrémolière A, Darmon M, Hamon M, Emerit MB. Immunolabelling of the 5-HT 3B receptor subunit in the central and peripheral nervous systems in rodents. The European Journal of Neuroscience. 26: 355-66. PMID 17650111 DOI: 10.1111/j.1460-9568.2007.05659.x  0.653
2007 Comet MA, Bernard JF, Hamon M, Laguzzi R, Sévoz-Couche C. Activation of nucleus tractus solitarius 5-HT2A but not other 5-HT2 receptor subtypes inhibits the sympathetic activity in rats. The European Journal of Neuroscience. 26: 345-54. PMID 17623018 DOI: 10.1111/j.1460-9568.2007.05673.x  0.47
2007 Schmitt A, Benninghoff J, Moessner R, Rizzi M, Paizanis E, Doenitz C, Gross S, Hermann M, Gritti A, Lanfumey L, Fritzen S, Reif A, Hamon M, Murphy DL, Vescovi A, et al. Adult neurogenesis in serotonin transporter deficient mice. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 1107-19. PMID 17510734 DOI: 10.1007/S00702-007-0724-6  0.388
2007 Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA, Hamon M, Bourgoin S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain. 130: 235-48. PMID 17250964 DOI: 10.1016/j.pain.2006.11.015  0.401
2007 Aubel B, Kayser V, Farré A, Hamon M, Bourgoin S. Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy. Neuropharmacology. 52: 487-96. PMID 17027046 DOI: 10.1016/j.neuropharm.2006.08.017  0.448
2006 Carrel D, Hamon M, Darmon M. Role of the C-terminal di-leucine motif of 5-HT1A and 5-HT1B serotonin receptors in plasma membrane targeting. Journal of Cell Science. 119: 4276-84. PMID 17003106 DOI: 10.1242/jcs.03189  0.582
2006 Kelaï S, Hanoun N, Aufrère G, Beaugé F, Hamon M, Lanfumey L. Cannabinoid-serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice. Journal of Neurochemistry. 99: 308-20. PMID 16987253 DOI: 10.1111/j.1471-4159.2006.04054.x  0.372
2006 Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Molecular Pharmacology. 70: 1013-21. PMID 16772521 DOI: 10.1124/mol.106.022756  0.638
2006 Sévoz-Couche C, Comet MA, Bernard JF, Hamon M, Laguzzi R. Cardiac baroreflex facilitation evoked by hypothalamus and prefrontal cortex stimulation: role of the nucleus tractus solitarius 5-HT2A receptors. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 291: R1007-15. PMID 16763082 DOI: 10.1152/ajpregu.00052.2006  0.388
2006 Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP, Hamon M, Adrien J. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5554-64. PMID 16707806 DOI: 10.1523/Jneurosci.5156-05.2006  0.418
2006 Masson J, Darmon M, Conjard A, Chuhma N, Ropert N, Thoby-Brisson M, Foutz AS, Parrot S, Miller GM, Jorisch R, Polan J, Hamon M, Hen R, Rayport S. Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 4660-71. PMID 16641247 DOI: 10.1523/Jneurosci.4241-05.2006  0.538
2006 Guignabert C, Izikki M, Tu LI, Li Z, Zadigue P, Barlier-Mur AM, Hanoun N, Rodman D, Hamon M, Adnot S, Eddahibi S. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circulation Research. 98: 1323-30. PMID 16614302 DOI: 10.1161/01.RES.0000222546.45372.a0  0.316
2006 Rumajogee P, Vergé D, Hamon M, Miquel MC. Somato-dendritic distribution of 5-HT(1A) and 5-HT(1B) autoreceptors in the BDNF- and cAMP-differentiated RN46A serotoninergic raphe cell line. Brain Research. 1085: 121-6. PMID 16579976 DOI: 10.1016/j.brainres.2006.02.086  0.422
2006 Evrard A, Barden N, Hamon M, Adrien J. Glucocorticoid receptor-dependent desensitization of 5-HT1A autoreceptors by sleep deprivation: studies in GR-i transgenic mice. Sleep. 29: 31-6. PMID 16453979 DOI: 10.1093/Sleep/29.1.31  0.394
2006 Hamon M, Bourgoin S. Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects? European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70008-6  0.379
2005 Lanfumey L, Hamon M. [Neurobiology of depression: new data]. Thã©Rapie. 60: 431-40. PMID 16433009 DOI: 10.2515/therapie:2005064  0.316
2005 Popa D, Léna C, Fabre V, Prenat C, Gingrich J, Escourrou P, Hamon M, Adrien J. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11231-8. PMID 16339018 DOI: 10.1523/Jneurosci.1724-05.2005  0.427
2005 Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice. Journal of Neurochemistry. 95: 1713-23. PMID 16219031 DOI: 10.1111/j.1471-4159.2005.03488.x  0.362
2005 Loiseau F, Le Bihan C, Hamon M, Thiébot MH. Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats. Psychopharmacology. 182: 24-32. PMID 15986188 DOI: 10.1007/s00213-005-0050-3  0.336
2005 Rumajogee P, Vergé D, Darmon M, Brisorgueil MJ, Hamon M, Miquel MC. Rapid up-regulation of the neuronal serotoninergic phenotype by brain-derived neurotrophic factor and cyclic adenosine monophosphate: relations with raphe astrocytes. Journal of Neuroscience Research. 81: 481-7. PMID 15968642 DOI: 10.1002/jnr.20572  0.6
2005 Guignabert C, Raffestin B, Benferhat R, Raoul W, Zadigue P, Rideau D, Hamon M, Adnot S, Eddahibi S. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation. 111: 2812-9. PMID 15927991 DOI: 10.1161/CIRCULATIONAHA.104.524926  0.349
2005 Meunier A, Latrémolière A, Mauborgne A, Bourgoin S, Kayser V, Cesselin F, Hamon M, Pohl M. Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 608-16. PMID 15771963 DOI: 10.1016/j.ymthe.2004.12.011  0.316
2005 Comet MA, Laguzzi R, Hamon M, Sévoz-Couche C. Functional interaction between nucleus tractus solitarius NK1 and 5-HT3 receptors in the inhibition of baroreflex in rats. Cardiovascular Research. 65: 930-9. PMID 15721874 DOI: 10.1016/j.cardiores.2004.11.012  0.325
2005 Renoir T, Saurini F, Hamon M, Lanfumey L. A124 MDMA-INDUCED LONG-TERM 5-HT1A RECEPTOR MODIFICATION IN MICE RAPHE DORSAL NUCLEUS Behavioural Pharmacology. 16: S62. DOI: 10.1097/00008877-200509001-00197  0.347
2004 Morley-Fletcher S, Darnaudéry M, Mocaer E, Froger N, Lanfumey L, Laviola G, Casolini P, Zuena AR, Marzano L, Hamon M, Maccari S. Chronic treatment with imipramine reverses immobility behaviour, hippocampal corticosteroid receptors and cortical 5-HT(1A) receptor mRNA in prenatally stressed rats. Neuropharmacology. 47: 841-7. PMID 15527818 DOI: 10.1016/J.Neuropharm.2004.06.011  0.408
2004 El Ganouni S, Hanoun N, Boni C, Tazi A, Hakkou F, Hamon M. Prevention of diazepam withdrawal syndrome by nifedipine-behavioural and neurochemical studies. Pharmacology, Biochemistry, and Behavior. 79: 269-77. PMID 15501302 DOI: 10.1016/j.pbb.2004.07.007  0.321
2004 Hanoun N, Mocaër E, Boyer PA, Hamon M, Lanfumey L. Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. Neuropharmacology. 47: 515-26. PMID 15380370 DOI: 10.1016/j.neuropharm.2004.06.003  0.474
2004 Pardon MC, Hanoun N, Perez-Diaz F, Joubert C, Launay JM, Christen Y, Hamon M, Cohen-Salmon C. Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice. Neurobiology of Aging. 25: 1067-83. PMID 15212832 DOI: 10.1016/j.neurobiolaging.2003.10.013  0.307
2004 Dubertret C, Hanoun N, Adès J, Hamon M, Gorwood P. Family-based association studies between 5-HT5A receptor gene and schizophrenia. Journal of Psychiatric Research. 38: 371-6. PMID 15203288 DOI: 10.1016/j.jpsychires.2004.01.002  0.334
2004 Riad M, Zimmer L, Rbah L, Watkins KC, Hamon M, Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5420-6. PMID 15190115 DOI: 10.1523/JNEUROSCI.0950-04.2004  0.459
2004 Comet MA, Sévoz-Couche C, Hanoun N, Hamon M, Laguzzi R. 5-HT-mediated inhibition of cardiovagal baroreceptor reflex response during defense reaction in the rat. American Journal of Physiology. Heart and Circulatory Physiology. 287: H1641-9. PMID 15165987 DOI: 10.1152/ajpheart.01204.2003  0.422
2004 David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. European Journal of Pharmacology. 492: 41-8. PMID 15145704 DOI: 10.1016/J.Ejphar.2004.03.016  0.432
2004 Mannoury la Cour C, Hanoun N, Melfort M, Hen R, Lesch KP, Hamon M, Lanfumey L. GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors. Journal of Neurochemistry. 89: 886-96. PMID 15140188 DOI: 10.1111/j.1471-4159.2004.02367.x  0.448
2004 Becker C, Andre J, Zeau B, Rettori MC, Guardiola-Lemaitre B, Hamon M, Benoliel JJ. Melatonin MT(1/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat. Neuropharmacology. 46: 1158-67. PMID 15111022 DOI: 10.1016/j.neuropharm.2004.02.006  0.342
2004 Meunier A, Braz J, Cesselin F, Hamon M, Pohl M. [From inflammation to pain: experimental gene therapy]. Mã©Decine Sciences : M/S. 20: 325-30. PMID 15067578 DOI: 10.1051/medsci/2004203325  0.624
2004 Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, Simonneau G, Hamon M, Adnot S, Eddahibi S. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circulation Research. 94: 1263-70. PMID 15059929 DOI: 10.1161/01.RES.0000126847.27660.69  0.365
2004 Dubertret C, Hanoun N, Adès J, Hamon M, Gorwood P. Family-based association study of the serotonin-6 receptor gene (C267T polymorphism) in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 126: 10-5. PMID 15048641 DOI: 10.1002/ajmg.b.20120  0.336
2004 Froger N, Palazzo E, Boni C, Hanoun N, Saurini F, Joubert C, Dutriez-Casteloot I, Enache M, Maccari S, Barden N, Cohen-Salmon C, Hamon M, Lanfumey L. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 2787-96. PMID 15028772 DOI: 10.1523/Jneurosci.4132-03.2004  0.343
2004 Rumajogee P, Vergé D, Hanoun N, Brisorgueil MJ, Hen R, Lesch KP, Hamon M, Miquel MC. Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP. The European Journal of Neuroscience. 19: 937-44. PMID 15009141 DOI: 10.1111/j.0953-816X.2004.03194.x  0.437
2004 Lanfumey L, Hamon M. 5-HT1 receptors. Current Drug Targets. Cns and Neurological Disorders. 3: 1-10. PMID 14965240 DOI: 10.2174/1568007043482570  0.452
2004 Roubert C, Spielewoy C, Soubrié P, Hamon M, Giros B, Betancur C. Altered neurotensin mrna expression in mice lacking the dopamine transporter. Neuroscience. 123: 537-46. PMID 14698760 DOI: 10.1016/J.Neuroscience.2003.08.022  0.559
2004 Loiseau F, Hamon M, Thiebot M. P35 EFFECTS OF MELATONIN MT1/2 RECEPTOR AGONISTS ON ANXIETY-RELATED BEHAVIOUR IN RATS: INTERACTION WITH DIAZEPAM Behavioural Pharmacology. 15: A18. DOI: 10.1097/00008877-200409000-00075  0.345
2003 Bouali S, Evrard A, Chastanet M, Lesch KP, Hamon M, Adrien J. Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. The European Journal of Neuroscience. 18: 2203-12. PMID 14622181 DOI: 10.1046/J.1460-9568.2003.02960.X  0.383
2003 Côté F, Thévenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA, Bayard E, Hanoun N, Saurini F, Lechat P, Dandolo L, Hamon M, Mallet J, Vodjdani G. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proceedings of the National Academy of Sciences of the United States of America. 100: 13525-30. PMID 14597720 DOI: 10.1073/pnas.2233056100  0.582
2003 Ballet S, Conrath M, Fischer J, Kaneko T, Hamon M, Cesselin F. Expression and g-protein coupling of μ-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats Neuropeptides. 37: 211-219. PMID 12906839 DOI: 10.1016/S0143-4179(03)00045-3  0.372
2003 Kelaï S, Aïssi F, Lesch KP, Cohen-Salmon C, Hamon M, Lanfumey L. Alcohol intake after serotonin transporter inactivation in mice. Alcohol and Alcoholism (Oxford, Oxfordshire). 38: 386-9. PMID 12814910 DOI: 10.1093/alcalc/agg095  0.303
2003 Sévoz-Couche C, Comet M-, Hamon M, Laguzzi R. Role of nucleus tractus solitarius 5-HT3 receptors in the defense reaction-induced inhibition of the aortic baroreflex in rats. Journal of Neurophysiology. 90: 2521-2530. PMID 12773495 DOI: 10.1152/Jn.00275.2003  0.435
2003 Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, Eddahibi S. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. 168: 487-93. PMID 12773327 DOI: 10.1164/RCCM.200210-1212OC  0.375
2003 Hanoun N, Saurini F, Lanfumey L, Hamon M, Bourgoin S. Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain. British Journal of Pharmacology. 139: 424-34. PMID 12770948 DOI: 10.1038/sj.bjp.0705258  0.471
2003 Pohl M, Meunier A, Hamon M, Braz J. Gene therapy of chronic pain Current Gene Therapy. 3: 223-238. PMID 12762481 DOI: 10.2174/1566523034578348  0.615
2003 Monaca C, Boutrel B, Hen R, Hamon M, Adrien J. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 850-6. PMID 12637954 DOI: 10.1038/Sj.Npp.1300109  0.434
2003 Rumajogee P, Madeira A, Vergé D, Hamon M, Miquel MC. Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. Journal of Neurochemistry. 83: 1525-8. PMID 12472905 DOI: 10.1046/j.1471-4159.2002.01264.x  0.381
2003 Kayser V, Aubel B, Hamon M, Bourgoin S. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. British Journal of Pharmacology. 137: 1287-97. PMID 12466238 DOI: 10.1038/sj.bjp.0704979  0.401
2003 Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Menziani MC, De Benedetti PG, Giorgi G, Ghelardini C, Collina S. Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities. Bioorganic & Medicinal Chemistry. 10: 779-801. PMID 11814868 DOI: 10.1016/S0968-0896(01)00332-7  0.439
2002 Nosjean A, Hamon M, Darmon M. 5-HT2A receptors are expressed by catecholaminergic neurons in the rat nucleus tractus solitarii. Neuroreport. 13: 2365-9. PMID 12488828 DOI: 10.1097/00001756-200212030-00039  0.646
2002 Alvarez C, Vitalis T, Fon EA, Hanoun N, Hamon M, Seif I, Edwards R, Gaspar P, Cases O. Effects of genetic depletion of monoamines on somatosensory cortical development. Neuroscience. 115: 753-64. PMID 12435414 DOI: 10.1016/S0306-4522(02)00484-0  0.337
2002 Sévoz-Couche C, Hamon M, Laguzzi R. Antinociceptive effect of cardiopulmonary chemoreceptor and baroreceptor reflex activation in the rat. Pain. 99: 71-81. PMID 12237185 DOI: 10.1016/S0304-3959(02)00055-6  0.332
2002 Nosjean A, Callera JC, Bonagamba L, Machado B, Hamon M, Laguzzi R. Serotonin3 receptor stimulation in the nucleus tractus solitarii activates non-catecholaminergic neurons in the rat ventrolateral medulla Neuroscience. 112: 935-949. PMID 12088752 DOI: 10.1016/S0306-4522(02)00057-X  0.441
2002 Ballet S, Braz J, Mauborgne A, Bourgoin S, Zajac JM, Hamon M, Cesselin F. The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord Journal of Neurochemistry. 81: 659-662. PMID 12065675 DOI: 10.1046/j.1471-4159.2002.00914.x  0.667
2002 Emerit MB, Doucet E, Darmon M, Hamon M. Native and cloned 5-HT(3A)(S) receptors are anchored to F-actin in clonal cells and neurons. Molecular and Cellular Neurosciences. 20: 110-24. PMID 12056843 DOI: 10.1006/mcne.2002.1133  0.622
2002 Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Hamon M, De Benedetti PG, Menziani MC. The Interactions of the 5-HT(3) receptor with arylpiperazine, tropane, and quinuclidine ligands. Current Topics in Medicinal Chemistry. 2: 599-624. PMID 12052196 DOI: 10.2174/1568026023393813  0.405
2002 Eddahibi S, Raffestin B, Hamon M, Adnot S. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? The Journal of Laboratory and Clinical Medicine. 139: 194-201. PMID 12024106 DOI: 10.1067/MLC.2002.122181  0.375
2002 Mauborgne A, Poliénor H, Hamon M, Cesselin F, Bourgoin S. Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord. European Journal of Pharmacology. 441: 47-55. PMID 12007919 DOI: 10.1016/S0014-2999(01)01619-3  0.376
2002 Sévoz-Couche C, Maisonneuve B, Hamon M, Laguzzi R. Glutamate and NO mediation of the pressor response to 5-HT3 receptor stimulation in the nucleus tractus solitarii. Neuroreport. 13: 837-41. PMID 11997697 DOI: 10.1097/00001756-200205070-00020  0.446
2002 Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle M. Association of 5-HT2A receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk Biological Psychiatry. 51: 762-765. PMID 11983190 DOI: 10.1016/S0006-3223(01)01228-8  0.325
2002 Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, Seif I, De Maeyer E, Gardier A, Hamon M, Adrien J. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. The European Journal of Neuroscience. 15: 841-51. PMID 11906526 DOI: 10.1046/J.1460-9568.2002.01917.X  0.449
2002 Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension. Chest. 121: 97S-98S. PMID 11893722 DOI: 10.1378/Chest.121.3_Suppl.97S  0.511
2002 Miquel MC, Emerit MB, Nosjean A, Simon A, Rumajogee P, Brisorgueil MJ, Doucet E, Hamon M, Vergé D. Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system. The European Journal of Neuroscience. 15: 449-57. PMID 11876772 DOI: 10.1046/j.0953-816x.2001.01872.x  0.476
2002 Gorwood P, Aissi F, Batel P, Adès J, Cohen-Salmon C, Hamon M, Boni C, Lanfumey L. Reappraisal of the serotonin 5-HT(1B) receptor gene in alcoholism: of mice and men. Brain Research Bulletin. 57: 103-7. PMID 11827742 DOI: 10.1016/S0361-9230(01)00641-4  0.366
2002 Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche JL, Launay JM, Gillberg C, Mouren-Siméoni MC, Hamon M, Giros B, Nosten-Bertrand M, Leboyer M. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Molecular Psychiatry. 7: 67-71. PMID 11803447 DOI: 10.1038/Sj/Mp/4000923  0.563
2002 Nevo I, Becker C, Hamon M, Benoliel J. Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat : Prevention by diazepam but not ondansetron Journal of Neurochemistry. 66: 2041-2049. PMID 8780034 DOI: 10.1046/J.1471-4159.1996.66052041.X  0.365
2002 Pohl M, Collin E, Bourgoin S, Conrath M, Benoliel JJ, Nevo I, Hamon M, Giraud P, Cesselin F. Expression of preproenkephalin A gene and presence of Met-enkephalin in dorsal root ganglia of the adult rat. Journal of Neurochemistry. 63: 1226-1234. PMID 7931276 DOI: 10.1046/J.1471-4159.1994.63041226.X  0.317
2001 Spielewoy C, Biala G, Roubert C, Hamon M, Betancur C, Giros B. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology. 159: 2-9. PMID 11797063 DOI: 10.1007/S002130100901  0.591
2001 Courade JP, Caussade F, Martin K, Besse D, Delchambre C, Hanoun N, Hamon M, Eschalier A, Cloarec A. Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn-Schmiedeberg's Archives of Pharmacology. 364: 534-7. PMID 11770008 DOI: 10.1007/s002100100484  0.437
2001 Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C, De Felipe C, Rupniak NM, Hunt SP, Jacquot C, Hamon M, Lanfumey L. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 8188-97. PMID 11588191 DOI: 10.1523/Jneurosci.21-20-08188.2001  0.453
2001 Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M, Pohl M. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons Journal of Neuroscience. 21: 7881-7888. PMID 11588161 DOI: 10.1523/Jneurosci.21-20-07881.2001  0.654
2001 N'Diaye A, Sévoz-Couche C, Nosjean A, Hamon M, Laguzzi R. Stimulation of 5-HT2 receptors in the nucleus tractus solitarius enhances NMDA receptor-mediated reflex-evoked bradycardiac responses in the rat. Autonomic Neuroscience: Basic and Clinical. 92: 45-55. PMID 11570703 DOI: 10.1016/S1566-0702(01)00318-6  0.438
2001 Beaufour CC, Le Bihan C, Hamon M, Thiébot M. Extracellular dopamine in the rat prefrontal cortex during reward-, punishment- and novelty-associated behaviour. Effects of diazepam. Pharmacology, Biochemistry, and Behavior. 69: 133-42. PMID 11420078 DOI: 10.1016/S0091-3057(01)00492-0  0.313
2001 Sagné C, Agulhon C, Ravassard P, Darmon M, Hamon M, El Mestikawy S, Gasnier B, Giros B. Identification and characterization of a lysosomal transporter for small neutral amino acids. Proceedings of the National Academy of Sciences of the United States of America. 98: 7206-11. PMID 11390972 DOI: 10.1073/Pnas.121183498  0.736
2001 Antunes bras J, Becker C, Bourgoin S, Lombard M, Cesselin F, Hamon M, Pohl M. Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats. Neuroscience. 103: 1073-83. PMID 11301214 DOI: 10.1016/S0306-4522(01)00034-3  0.326
2001 Beaufour CC, Bihan CL, Hamon M, Thiebot M. Extracellular serotonin is enhanced in the striatum, but not in the dorsal hippocampus or prefrontal cortex, in rats subjected to an operant conflict procedure. Behavioral Neuroscience. 115: 125-137. PMID 11256436 DOI: 10.1037/0735-7044.115.1.125  0.42
2001 Ballet S, Aubel B, Mauborgne A, Poliénor H, Farré A, Cesselin F, Hamon M, Bourgoin AS. The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats. Neuropharmacology. 40: 578-589. PMID 11249967 DOI: 10.1016/S0028-3908(00)00186-6  0.309
2001 Riad M, Watkins KC, Doucet E, Hamon M, Descarries L. Agonist-Induced Internalization of Serotonin-1A Receptors in the Dorsal Raphe Nucleus (Autoreceptors) But Not Hippocampus (Heteroreceptors) The Journal of Neuroscience. 21: 8378-8386. DOI: 10.1523/JNEUROSCI.21-21-08378.2001  0.476
2001 Cour CMl, Boni C, Hanoun N, Lesch K, Hamon M, Lanfumey L. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. The Journal of Neuroscience. 21: 2178-2185. DOI: 10.1523/Jneurosci.21-06-02178.2001  0.488
2001 Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, Maeyer ED, Murphy DL, Mössner R, Lesch KP, Hen R, Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. The Journal of Neuroscience. 21: 884-896. DOI: 10.1523/Jneurosci.21-03-00884.2001  0.422
2001 Becker C, Thiébot M, Touitou Y, Hamon M, Cesselin F, Benoliel J. Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat The Journal of Neuroscience. 21: 262-269. DOI: 10.1523/Jneurosci.21-01-00262.2001  0.314
2000 Ahnaou A, Laporte AM, Ballet S, Escourrou P, Hamon M, Adrien J, Bourgin P. Muscarinic and PACAP receptor interactions at pontine level in the rat: significance for REM sleep regulation. The European Journal of Neuroscience. 12: 4496-504. PMID 11122360 DOI: 10.1046/J.0953-816X.2000.01345.X  0.323
2000 Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behavioural Pharmacology. 11: 279-90. PMID 11103882 DOI: 10.1097/00008877-200006000-00011  0.521
2000 Lanfumey L, Mannoury La Cour C, Froger N, Hamon M. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochemical Research. 25: 1199-206. PMID 11059794 DOI: 10.1023/A:1007683810230  0.4
2000 Bonagamba LGH, Sévoz-Couche C, N'Diaye A, Uygun-Louvet K, Callera J-, Machado BH, Hamon M, Laguzzi R. Bradycardic responses to microinjection of N-methyl-D-aspartate into the nucleus tractus solitarius are inhibited by local activation of 5-HT3 receptors Neuropharmacology. 39: 2336-2345. PMID 10974317 DOI: 10.1016/S0028-3908(00)00093-9  0.446
2000 Lanfumey L, Hamon M. Central 5-HT(1A) receptors: regional distribution and functional characteristics. Nuclear Medicine and Biology. 27: 429-35. PMID 10962246 DOI: 10.1016/S0969-8051(00)00107-4  0.44
2000 Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. The European Journal of Neuroscience. 12: 2299-310. PMID 10947809 DOI: 10.1046/J.1460-9568.2000.00126.X  0.465
2000 Brailov I, Bancila M, Brisorgueil MJ, Miquel MC, Hamon M, Vergé D. Localization of 5-HT6 receptors at the plasma membrane of neuronal cilia in the rat brain Brain Research. 872: 271-275. PMID 10924708 DOI: 10.1016/S0006-8993(00)02519-1  0.453
2000 Ballet S, Mauborgne A, Hamon M, Cesselin F, Collin E. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats. Synapse. 37: 262-272. PMID 10891863 DOI: 10.1002/1098-2396(20000915)37:4<262::Aid-Syn3>3.0.Co;2-6  0.329
2000 Fabre V, Boutrel B, Hanoun N, Lanfumey L, Fattaccini CM, Demeneix B, Adrien J, Hamon M, Martres MP. Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5065-75. PMID 10864964 DOI: 10.1523/Jneurosci.20-13-05065.2000  0.481
2000 Spielewoy C, Gonon F, Roubert C, Fauchey V, Jaber M, Caron MG, Roques BP, Hamon M, Betancur C, Maldonado R, Giros B. Increased rewarding properties of morphine in dopamine-transporter knockout mice. The European Journal of Neuroscience. 12: 1827-37. PMID 10792459 DOI: 10.1046/J.1460-9568.2000.00063.X  0.62
2000 Masson J, Gaspar P, Aïdouni Z, Ezan P, Giros B, Hamon M, El Mestikawy S. Ontogeny of Rxt1, a vesicular "orphan" Na(+)/Cl(-)-dependent transporter, in the rat. Neuroscience. 96: 627-37. PMID 10717444 DOI: 10.1016/S0306-4522(99)00570-9  0.683
2000 Becker C, Pohl M, Thiébot M, Collin E, Hamon M, Cesselin F, Benoliel J. δ-Opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats Neuropharmacology. 39: 161-171. PMID 10670411 DOI: 10.1016/S0028-3908(99)00161-6  0.308
2000 Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J, Hamon M, Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology. 39: 110-22. PMID 10665824 DOI: 10.1016/S0028-3908(99)00088-X  0.473
2000 Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, el Mestikawy S, Hamon M, Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. The Journal of Comparative Neurology. 417: 181-94. PMID 10660896 DOI: 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A  0.663
2000 Jolimay N, Franck L, Langlois X, Hamon M, Darmon M. Dominant Role of the Cytosolic C-Terminal Domain of the Rat 5-HT1BReceptor in Axonal–Apical Targeting The Journal of Neuroscience. 20: 9111-9118. DOI: 10.1523/JNEUROSCI.20-24-09111.2000  0.568
2000 Hamon M. The Main Features of Central 5-HT1A Receptors Neuropsychopharmacology. 3: 239-268. DOI: 10.1007/978-3-642-60921-3_9  0.4
1999 Doucet E, Miquel MC, Nosjean A, Vergé D, Hamon M, Emerit MB. Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor. Neuroscience. 95: 881-892. PMID 10670455 DOI: 10.1016/S0306-4522(99)00494-7  0.453
1999 Lanfumey L, Pardon MC, Laaris N, Joubert C, Hanoun N, Hamon M, Cohen-Salmon C. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport. 10: 3369-74. PMID 10599847 DOI: 10.1097/00001756-199911080-00021  0.382
1999 Evrard A, Laporte AM, Chastanet M, Hen R, Hamon M, Adrien J. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice. The European Journal of Neuroscience. 11: 3823-31. PMID 10583471 DOI: 10.1046/J.1460-9568.1999.00800.X  0.456
1999 Bizot J-, Bihan CL, Puech AJ, Hamon M, Thiébot M-. Serotonin and tolerance to delay of reward in rats. Psychopharmacology. 146: 400-412. PMID 10550490 DOI: 10.1007/Pl00005485  0.374
1999 Masson J, Cervera P, Côté S, Morisette J, Aïdouni Z, Giros B, Hamon M, Falardeau P, Mestikawy SE. Characterization and distribution of Hxt1, a Na(+)/Cl(-)-dependent orphan transporter, in the human brain. Journal of Neuroscience Research. 56: 146-59. PMID 10494103 DOI: 10.1002/(Sici)1097-4547(19990415)56:2<146::Aid-Jnr4>3.0.Co;2-#  0.557
1999 Becker C, Hamon M, Cesselin F, Benoliel J. Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat. Synapse. 34: 47-54. PMID 10459171 DOI: 10.1002/(Sici)1098-2396(199910)34:1<47::Aid-Syn6>3.0.Co;2-9  0.308
1999 Hamon M, Doucet E, Lefèvre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Vergé D. Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 68S-76S. PMID 10432491 DOI: 10.1016/S0893-133X(99)00044-5  0.47
1999 Otano A, Frechilla D, Cobreros A, Cruz-Orive LM, Insausti A, Insausti R, Hamon M, Rio JD. Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience. 92: 1001-1009. PMID 10426540 DOI: 10.1016/S0306-4522(99)00066-4  0.411
1999 Fischer J, Bancila V, Mailly P, Masson J, Hamon M, El Mestikawy S, Conrath M. Immunocytochemical evidence of vesicular localization of the orphan transporter RXT1 in the rat spinal cord. Neuroscience. 92: 729-43. PMID 10408621 DOI: 10.1016/S0306-4522(99)00017-2  0.609
1999 Laaris N, Le Poul E, Laporte AM, Hamon M, Lanfumey L. Differential effects of stress on presynaptic and postsynaptic 5-hydroxytryptamine-1A receptors in the rat brain: an in vitro electrophysiological study. Neuroscience. 91: 947-58. PMID 10391473 DOI: 10.1016/S0306-4522(98)00674-5  0.389
1999 Sari Y, Miquel MC, Brisorgueil MJ, Ruiz G, Doucet E, Hamon M, Vergé D. Cellular and subcellular localization of 5-hydroxytryptamine(1B) receptors in the rat central nervous system: Immunocytochemical, autoradiographic and lesion studies Neuroscience. 88: 899-915. PMID 10363826 DOI: 10.1016/S0306-4522(98)00256-5  0.382
1999 Becker C, Hamon M, Benoliel JJ. Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat. Neuropharmacology. 38: 525-32. PMID 10221756 DOI: 10.1016/S0028-3908(98)00209-3  0.354
1999 Rioux A, Fabre V, Lesch KP, Moessner R, Murphy DL, Lanfumey L, Hamon M, Martres MP. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neuroscience Letters. 262: 113-6. PMID 10203244 DOI: 10.1016/S0304-3940(99)00049-X  0.432
1999 Masson J, Riad M, Chaudhry F, Darmon M, Aïdouni Z, Conrath M, Giros B, Hamon M, Storm-Mathisen J, Descarries L, El Mestikawy S. Unexpected localization of the Na+/Cl--dependent-like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system. The European Journal of Neuroscience. 11: 1349-61. PMID 10103130 DOI: 10.1046/J.1460-9568.1999.00540.X  0.754
1999 Sari Y, Sibella C, Vergé D, Hamon M, Miquel MC. Limited inhibition of 5-HT(1A) receptor expression in the rat brain by antisense RNA and oligodesoxynucleotides Neuroscience Letters. 259: 191-195. PMID 10025590 DOI: 10.1016/S0304-3940(98)00925-2  0.448
1999 Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circulation Research. 84: 329-36. PMID 10024307 DOI: 10.1161/01.Res.84.3.329  0.398
1999 Le Poul E, Laaris N, Doucet E, Fattaccini CM, Mocaër E, Hamon M, Lanfumey L. Chronic alnespirone-induced desensitization of somatodendritic 5-HT1A autoreceptors in the rat dorsal raphe nucleus. European Journal of Pharmacology. 365: 165-73. PMID 9988099 DOI: 10.1016/S0014-2999(98)00886-3  0.448
1999 Bras JMA, Laporte A, Benoliel JJ, Bourgoin S, Mauborgne A, Hamon M, Cesselin F, Pohl M. Effects of Peripheral Axotomy on Cholecystokinin Neurotransmission in the Rat Spinal Cord Journal of Neurochemistry. 72: 858-867. PMID 9930763 DOI: 10.1046/J.1471-4159.1999.720858.X  0.35
1998 Martres MP, Demeneix B, Hanoun N, Hamon M, Giros B. Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain. The European Journal of Neuroscience. 10: 3607-16. PMID 9875340 DOI: 10.1046/J.1460-9568.1998.00366.X  0.55
1998 Darmon M, Langlois X, Suffisseau L, Fattaccini CM, Hamon M. Differential membrane targeting and pharmacological characterization of chimeras of rat serotonin 5-HT(1A) and 5-HT(1B) receptors expressed in epithelial LLC-PK1 cells Journal of Neurochemistry. 71: 2294-2303. PMID 9832127 DOI: 10.1046/J.1471-4159.1998.71062294.X  0.653
1998 Doucet E, Hamon M, Emerit MB. Immunolabelling of the rat intestinal tract with antibodies specific to the long form of the 5-hydroxytryptamine3 receptor Neuroscience. 87: 691-707. PMID 9758234 DOI: 10.1016/S0306-4522(98)00184-5  0.388
1998 Riad M, Tong XK, el Mestikawy S, Hamon M, Hamel E, Descarries L. Endothelial expression of the 5-hydroxytryptamine1B antimigraine drug receptor in rat and human brain microvessels. Neuroscience. 86: 1031-5. PMID 9697110 DOI: 10.1016/S0306-4522(98)00196-1  0.634
1998 Dugast C, Soulière F, Schmitt P, Casanovas JM, Fattaccini CM, Mocaër E, Lesourd M, Renaud B, Artigas F, Hamon M, Chouvet G. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain? European Journal of Pharmacology. 350: 171-80. PMID 9696405 DOI: 10.1016/S0014-2999(98)00254-4  0.433
1998 Ballet S, Mauborgne A, Benoliel J, Bourgoin S, Hamon M, Cesselin F, Collin E. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat Brain Research. 796: 198-208. PMID 9689470 DOI: 10.1016/S0006-8993(98)00350-3  0.355
1998 Sévoz-Couche C, Nosjean A, Franc B, Hamon M, Laguzzi R. Dorsal medullary 5-HT3 receptors and sympathetic premotor neurones in the rat. The Journal of Physiology. 747-62. PMID 9518730 DOI: 10.1111/j.1469-7793.1998.747bp.x  0.429
1998 Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Bruni G, Romeo MR, Menziani MC, Benedetti aPGD, Langer T. Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 1. Mapping the Central 5-HT3 Receptor Binding Site by Arylpiperazine Derivatives Journal of Medicinal Chemistry. 41: 728-741. PMID 9513601 DOI: 10.1021/Jm970645I  0.438
1998 Nosjean A, Hamon M, Laguzzi R. c-Fos induction in the rostroventrolateral medulla by 5-HT3 receptor activation in the nucleus tractus solitarius Neuroreport. 9: 373-378. PMID 9512374 DOI: 10.1097/00001756-199802160-00003  0.462
1998 Corradetti R, Laaris N, Hanoun N, Laporte AM, Le Poul E, Hamon M, Lanfumey L. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. British Journal of Pharmacology. 123: 449-62. PMID 9504386 DOI: 10.1038/sj.bjp.0701632  0.357
1998 Antunes Bras JM, Epstein AL, Bourgoin S, Hamon M, Cesselin F, Pohl M. Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. Journal of Neurochemistry. 70: 1299-303. PMID 9489753 DOI: 10.1046/j.1471-4159.1998.70031299.x  0.311
1998 Spielewoy C, Roubert C, Hamon M, Giros B. Implication of transgenic models for mental disorders: Study of the dopamine neurotransmission system European Neuropsychopharmacology. 8: S119. DOI: 10.1016/S0924-977X(98)80105-3  0.496
1997 Lima L, Laporte AM, Gaymard C, Spedding M, Mocaër E, Hamon M. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors. Journal of Neural Transmission. 104: 1059-1075. PMID 9503258 DOI: 10.1007/Bf01273319  0.366
1997 el Mestikawy S, Wehrlé R, Masson J, Lombard MC, Hamon M, Sotelo C. Distribution pattern and ultrastructural localization of Rxt1, an orphan Na+/Cl(-)-dependent transporter, in the central nervous system of rats and mice. Neuroscience. 77: 319-33. PMID 9472393 DOI: 10.1016/S0306-4522(96)00466-6  0.614
1997 Fabre V, Boni C, Mocaër E, Lesourd M, Hamon M, Laporte AM. [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain. European Journal of Pharmacology. 337: 297-308. PMID 9430429 DOI: 10.1016/S0014-2999(97)01288-0  0.385
1997 Sagné C, El Mestikawy S, Isambert MF, Hamon M, Henry JP, Giros B, Gasnier B. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. Febs Letters. 417: 177-83. PMID 9395291 DOI: 10.1016/S0014-5793(97)01279-9  0.68
1997 Le Poul E, Laaris N, Hamon M, Lanfumey L. Fluoxetine-induced desensitization of somatodendritic 5-HT1A autoreceptors is independent of glucocorticoid(s). Synapse (New York, N.Y.). 27: 303-12. PMID 9372553 DOI: 10.1002/(SICI)1098-2396(199712)27:4<303::AID-SYN4>3.0.CO;2-G  0.451
1997 Laaris N, Le Poul E, Hamon M, Lanfumey L. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus--in vitro electrophysiological evidence. Fundamental & Clinical Pharmacology. 11: 206-14. PMID 9243251 DOI: 10.1111/J.1472-8206.1997.Tb00187.X  0.394
1997 Sari Y, Lefèvre K, Bancila M, Quignon M, Miquel MC, Langlois X, Hamon M, Vergé D. Light and electron microscopic immunocytochemical visualization of 5- HT(1B) receptors in the rat brain Brain Research. 760: 281-286. PMID 9237548 DOI: 10.1016/S0006-8993(97)00400-9  0.43
1997 Maudhuit C, Prévot E, Dangoumau L, Martin P, Hamon M, Adrien J. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology. 130: 269-75. PMID 9151362 DOI: 10.1007/S002130050239  0.406
1997 Lanfumey L, Haj-Dahmane S, Laporte AM, Martin P, Hamon M, Gozlan H. Effects of chronic diazepam treatment on pre- and postsynaptic 5-HT1A receptors in the rat brain. European Journal of Pharmacology. 323: 137-48. PMID 9128832 DOI: 10.1016/S0014-2999(97)00032-0  0.408
1997 Sevoz C, Callera JC, Machado BH, Hamon M, Laguzzi R. Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex American Journal of Physiology-Heart and Circulatory Physiology. 272. PMID 9087599 DOI: 10.1152/Ajpheart.1997.272.3.H1250  0.441
1997 Pohl M, Ballet S, Collin E, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F. Enkephalinergic and dynorphinergic neurons in the spinal cord and dorsal root ganglia of the polyarthritic rat — in vivo release and cDNA hybridization studies Brain Research. 749: 18-28. PMID 9070623 DOI: 10.1016/S0006-8993(96)01161-4  0.326
1997 Gérard C, Martres MP, Lefèvre K, Miquel MC, Vergé D, Lanfumey L, Doucet E, Hamon M, el Mestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Research. 746: 207-19. PMID 9037500 DOI: 10.1016/S0006-8993(96)01224-3  0.693
1996 Prévot E, Maudhuit C, Le Poul E, Hamon M, Adrien J. Sleep deprivation reduces the citalopram-induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat. Journal of Sleep Research. 5: 238-45. PMID 9065875 DOI: 10.1111/J.1365-2869.1996.00238.X  0.398
1996 Delagrange P, Emerit MB, Merahi N, Abraham C, Morain P, Rault S, Renard P, Pfeiffer B, Guardiola-Lemaître B, Hamon M. Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization European Journal of Pharmacology. 316: 195-203. PMID 8982686 DOI: 10.1016/S0014-2999(96)00680-2  0.463
1996 Kia HK, Brisorgueil MJ, Hamon M, Calas A, Vergé D. Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. Journal of Neuroscience Research. 46: 697-708. PMID 8978504 DOI: 10.1002/(SICI)1097-4547(19961215)46:6<697::AID-JNR7>3.0.CO;2-A  0.422
1996 Maudhuit C, Jolas T, Chastanet M, Hamon M, Adrien J. Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biological Psychiatry. 40: 1000-7. PMID 8915559 DOI: 10.1016/0006-3223(95)00583-8  0.327
1996 Arvieu L, Mauborgne A, Bourgoin S, Oliver C, Feltz P, Hamon M, Cesselin F. Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport. 7: 1973-6. PMID 8905706 DOI: 10.1097/00001756-199608120-00023  0.322
1996 Sévoz C, Hamon M, Laguzzi R. Medullary pathways of cardiovascular responses to 5-HT2 and 5-HT3 receptor stimulation in the rat nucleus tractus solitarius Neuroreport. 7: 1965-1969. PMID 8905704 DOI: 10.1097/00001756-199608120-00021  0.461
1996 Langlois X, el Mestikawy S, Arpin M, Triller A, Hamon M, Darmon M. Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons. Neuroscience. 74: 297-302. PMID 8865182 DOI: 10.1016/0306-4522(96)00234-5  0.719
1996 Kia HK, Brisorgueil MJ, Daval G, Langlois X, Hamon M, Vergé D. Serotonin1A Receptors Are Expressed By A Subpopulation Of Cholinergic Neurons In The Rat Medial Septum And Diagonal Band Of Broca—A Double Immunocytochemical Study Neuroscience. 74: 143-154. PMID 8843083 DOI: 10.1016/0306-4522(96)00087-5  0.39
1996 Laporte AM, Doyen C, Nevo IT, Chauveau J, Hauw JJ, Hamon M. Autoradiographic mapping of serotonin 5-HT1A, 5-HT1D, 5-HT2A and 5-HT3 receptors in the aged human spinal cord. Journal of Chemical Neuroanatomy. 11: 67-75. PMID 8841890 DOI: 10.1016/0891-0618(96)00130-5  0.387
1996 Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Vergé D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. The Journal of Comparative Neurology. 365: 289-305. PMID 8822171 DOI: 10.1002/(SICI)1096-9861(19960205)365:2<289::AID-CNE7>3.0.CO;2-1  0.659
1996 Gérard C, el Mestikawy S, Lebrand C, Adrien J, Ruat M, Traiffort E, Hamon M, Martres MP. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse (New York, N.Y.). 23: 164-73. PMID 8807744 DOI: 10.1002/(Sici)1098-2396(199607)23:3<164::Aid-Syn5>3.0.Co;2-6  0.684
1996 Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, ... ... Hamon M, et al. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behavioural Brain Research. 73: 337-53. PMID 8788530 DOI: 10.1016/0166-4328(96)00118-0  0.451
1996 Sevoz C, Nosjean A, Callera JC, Machado B, Hamon M, Laguzzi R. Stimulation of 5-HT3 receptors in the NTS inhibits the cardiac Bezold-Jarisch reflex response. American Journal of Physiology-Heart and Circulatory Physiology. 271. PMID 8760161 DOI: 10.1152/Ajpheart.1996.271.1.H80  0.353
1996 Maudhuit C, Hamon M, Adrien J. Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression. Psychopharmacology. 124: 267-74. PMID 8740049 DOI: 10.1007/Bf02246667  0.385
1996 Rault S, Lancelot †J, Prunier H, Robba M, Renard P, Delagrange P, Pfeiffer B, Caignard ‡D, Guardiola-Lemaitre §aB, Hamon M. Novel Selective and Partial Agonists of 5-HT3 Receptors. Part 1. Synthesis and Biological Evaluation of Piperazinopyrrolothienopyrazines Journal of Medicinal Chemistry. 39: 2068-2080. PMID 8642566 DOI: 10.1021/Jm950543X  0.4
1995 Laporte AM, Fattaccini CM, Lombard MC, Chauveau J, Hamon M. Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B, and 5-HT3 receptors in the rat spinal cord. Journal of Neural Transmission. 100: 207-223. PMID 8748667 DOI: 10.1007/Bf01276459  0.449
1995 Masson J, Langlois X, Lanfumey L, Gérard C, Aïdouni Z, Giros B, Hamon M, el Mestikawy S. Immunolabeling of the Na+/Cl(-)-dependent "orphan" transporter Rxt1 in the rat central nervous system. Journal of Neuroscience Research. 42: 423-32. PMID 8583511 DOI: 10.1002/Jnr.490420317  0.699
1995 Laaris N, Haj-Dahmane S, Hamon M, Lanfumey L. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus. Neuropharmacology. 34: 1201-10. PMID 8532191 DOI: 10.1016/0028-3908(95)00095-N  0.47
1995 Nevo I, Langlois X, Laporte AM, Kleven M, Koek W, Lima L, Maudhuit C, Martres MP, Hamon M. Chronic alcoholization alters the expression of 5-HT1A and 5-HT1B receptor subtypes in rat brain. European Journal of Pharmacology. 281: 229-39. PMID 8521905 DOI: 10.1016/0014-2999(95)00238-G  0.398
1995 Kleven M, Ybema C, Carilla E, Hamon M, Koek W. Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence. European Journal of Pharmacology. 281: 219-28. PMID 8521904 DOI: 10.1016/0014-2999(95)00324-E  0.303
1995 Kia HK, Miquel MC, McKernan RM, Laporte AM, Lombard MC, Bourgoin S, Hamon M, Vergé D. Localization of 5-HT3 receptors in the rat spinal cord: immunohistochemistry and in situ hybridization. Neuroreport. 6: 257-61. PMID 7756605 DOI: 10.1097/00001756-199501000-00008  0.455
1995 Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. European Journal of Pharmacology. 288: 173-86. PMID 7720779 DOI: 10.1016/0922-4106(95)90192-2  0.336
1995 Doucet E, Pohl M, Fattaccini CM, Adrien J, Mestikawy SE, Hamon M. In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse (New York, N.Y.). 19: 18-28. PMID 7709340 DOI: 10.1002/Syn.890190104  0.403
1995 Miquel MC, Emerit MB, Gingrich JA, Nosjean A, Hamon M, el Mestikawy S. Developmental changes in the differential expression of two serotonin 5-HT3 receptor splice variants in the rat. Journal of Neurochemistry. 65: 475-83. PMID 7616200 DOI: 10.1046/J.1471-4159.1995.65020475.X  0.674
1995 Maudhuit C, Hamon M, Adrien J. Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport. 6: 681-4. PMID 7605927 DOI: 10.1097/00001756-199503000-00024  0.394
1995 Langlois X, Gérard C, Darmon M, Chauveau J, Hamon M, el Mestikawy S. Immunolabeling of central serotonin 5-HT1D beta receptors in the rat, mouse, and guinea pig with a specific anti-peptide antiserum. Journal of Neurochemistry. 65: 2671-81. PMID 7595565 DOI: 10.1046/J.1471-4159.1995.65062671.X  0.716
1995 Emerit MB, Martres MP, Miquel MC, el Mestikawy S, Hamon M. Differentiation alters the expression of the two splice variants of the serotonin 5-HT3 receptor-A mRNA in NG108-15 cells. Journal of Neurochemistry. 65: 1917-25. PMID 7595474 DOI: 10.1046/J.1471-4159.1995.65051917.X  0.632
1995 Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Archives of Pharmacology. 352: 141-8. PMID 7477436 DOI: 10.1007/BF00176767  0.443
1994 el Mestikawy S, Giros B, Pohl M, Hamon M, Kingsmore SF, Seldin MF, Caron MG. Characterization of an atypical member of the Na+/Cl(-)-dependent transporter family: chromosomal localization and distribution in GABAergic and glutamatergic neurons in the rat brain. Journal of Neurochemistry. 62: 445-55. PMID 8294906 DOI: 10.1046/J.1471-4159.1994.62020445.X  0.743
1994 Riad M, Hamon M, Emerit MB. Pharmacological evidence for the involvement of calcium/calmodulin in serotonin 5-HT3 receptor-mediated cation permeability in NG 108-15 cells Journal of Neurochemistry. 62: 2224-2232. PMID 8189230 DOI: 10.1046/j.1471-4159.1994.62062224.x  0.368
1994 Haj-Dahmane S, Jolas T, Laporte AM, Gozlan H, Farré AJ, Hamon M, Lanfumey L. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. European Journal of Pharmacology. 255: 185-96. PMID 8026543 DOI: 10.1016/0014-2999(94)90097-3  0.435
1994 Gozlan H, Laporte AM, Thibault S, Schechter LE, Bolaños F, Hamon M. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33: 423-31. PMID 7984280 DOI: 10.1016/0028-3908(94)90072-8  0.42
1994 Benoliel JJ, Collin E, Mauborgne A, Bourgoin S, Legrand JC, Hamon M, Cesselin F. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Brain Research. 653: 81-91. PMID 7982079 DOI: 10.1016/0006-8993(94)90375-1  0.351
1994 Collin E, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at ∂ opioid receptors Neuropeptides. 27: 75-83. PMID 7969822 DOI: 10.1016/0143-4179(94)90018-3  0.331
1994 Miquel MC, Kia HK, Boni C, Doucet E, Daval G, Matthiessen L, Hamon M, Vergé D. Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum. Brain Research. Developmental Brain Research. 80: 149-57. PMID 7955340 DOI: 10.1016/0165-3806(94)90099-X  0.345
1994 Hillion J, Catelon J, Raid M, Hamon M, De Vitry F. Neuronal localization of 5-HT1A receptor mRNA and protein in rat embryonic brain stem cultures. Brain Research. Developmental Brain Research. 79: 195-202. PMID 7955318 DOI: 10.1016/0165-3806(94)90124-4  0.402
1994 Charrier D, Dangoumau L, Hamon M, Puech AJ, Thiébot MH. Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat. Pharmacology, Biochemistry, and Behavior. 48: 281-9. PMID 7913228 DOI: 10.1016/0091-3057(94)90528-2  0.322
1994 Gérard C, Langlois X, Gingrich J, Doucet E, Vergé D, Kia HK, Raisman R, Gozlan H, el Mestikawy S, Hamon M. Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor. Neuroscience. 62: 721-39. PMID 7870302 DOI: 10.1016/0306-4522(94)90472-3  0.648
1994 Bourgoin S, Benoliel J, Collin E, Mauborgne A, Pohl M, Hamon M, Cesselin F. Opioidergic control of the spinal release of neuropeptides. Possible significance for the analgesic effects of opioids Fundamental & Clinical Pharmacology. 8: 307-321. PMID 7851837 DOI: 10.1111/J.1472-8206.1994.Tb00809.X  0.317
1994 Maudhuit C, Jolas T, Lainey E, Hamon M, Adrien J. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology. 33: 1017-25. PMID 7845548 DOI: 10.1016/0028-3908(94)90161-9  0.335
1994 Riad M, Emerit MB, Hamon M. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture Developmental Brain Research. 82: 245-258. PMID 7842512 DOI: 10.1016/0165-3806(94)90167-8  0.393
1994 Laporte AM, Lima L, Gozlan H, Hamon M. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. European Journal of Pharmacology. 271: 505-14. PMID 7705451 DOI: 10.1016/0014-2999(94)90812-5  0.374
1994 Benoliel JJ, Bourgoin S, Collin E, Mauborgne A, Pohl M, Thiébot MH, Hamon M, Cesselin F. Opioid control of the spinal release of cholecystokinin (CCK) in morphine-tolerant and non-tolerant rats Regulatory Peptides. 54: 23-24. DOI: 10.1016/0167-0115(94)90370-0  0.344
1994 Cesselin F, Collin E, Bourgoin S, Pohl M, Mauborgne A, Benoliel JJ, Hamon M. Kappa1/mu interactions in the control of the in vivo release of neuropeptides from the rat spinal cord Regulatory Peptides. 53. DOI: 10.1016/0167-0115(94)90266-6  0.345
1994 Collin E, Pohl M, Bourgoin S, Hamon M, Cesselin F. The control of CGRP-containing primary afferent fibers by mu opioids is altered in chronic suffering rats Regulatory Peptides. 53. DOI: 10.1016/0167-0115(94)90264-X  0.32
1993 Tissier MH, Lainey E, Fattaccini CM, Hamon M, Adrien J. Effects of ipsapirone, a 5-HT1A agonist, on sleep/wakefulness cycles: probable post-synaptic action. Journal of Sleep Research. 2: 103-109. PMID 10607079 DOI: 10.1111/J.1365-2869.1993.Tb00070.X  0.303
1993 Hillion J, Milne-Edwards JB, Catelon J, de Vitry F, Gros F, Hamon M. Prenatal developmental expression of rat brain 5-HT1A receptor gene followed by PCR. Biochemical and Biophysical Research Communications. 191: 991-7. PMID 8466538 DOI: 10.1006/bbrc.1993.1315  0.392
1993 Haj-Dahmane S, Laporte AM, Vantalon V, Fattaccini CM, Hamon M, Lanfumey L. Possible involvement of K(ATP) channels in the control of 5-HT neurons. Brain Research. 614: 270-8. PMID 8394188 DOI: 10.1016/0006-8993(93)91044-S  0.334
1993 Collin E, Frechilla D, Pohl M, Bourgoin S, Bars DL, Hamon M, Cesselin F. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo Brain Research. 609: 211-222. PMID 8389648 DOI: 10.1016/0006-8993(93)90875-N  0.346
1993 Matthiessen L, Kia HK, Daval G, Riad M, Hamon M, Vergé D. Immunocytochemical localization of 5-HT1A receptors in the rat immature cerebellum. Neuroreport. 4: 763-6. PMID 8347822 DOI: 10.1097/00001756-199306000-00042  0.447
1993 Kidd EJ, Laporte AM, Langlois X, Fattaccini CM, Doyen C, Lombard MC, Gozlan H, Hamon M. 5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals. Brain Research. 612: 289-98. PMID 8330206 DOI: 10.1016/0006-8993(93)91674-H  0.473
1993 Bachy A, Steinberg R, Santucci V, Fournier M, Landi M, Hamon M, Manara L, Keane P, Soubrié P, Fur GL. Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist Fundamental & Clinical Pharmacology. 7: 487-497. PMID 8314196 DOI: 10.1111/J.1472-8206.1993.Tb00253.X  0.406
1993 Lanfumey L, Haj-Dahmane S, Hamon M. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. European Journal of Pharmacology. 249: 25-35. PMID 8282017 DOI: 10.1016/0014-2999(93)90658-5  0.465
1993 Kidd FJ, Levy JC, Nielsen M, Hamon M, Gozlan H. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues. European Journal of Pharmacology. 247: 45-56. PMID 8258360 DOI: 10.1016/0922-4106(93)90136-W  0.405
1993 Collin E, Mantelet S, Frechilla D, Pohl M, Bourgoin S, Hamon M, Cesselin F. Increased in vivo release of calcitonin gene-related peptide-like material from the spinal cord in arthritic rats Pain. 54: 203-211. PMID 8233535 DOI: 10.1016/0304-3959(93)90210-G  0.348
1993 Bachy A, Héaulme M, Giudice A, Michaud JC, Lefevre IA, Souilhac J, Manara L, Emerit MB, Gozlan H, Hamon M. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. European Journal of Pharmacology. 237: 299-309. PMID 7689975 DOI: 10.1016/0014-2999(93)90282-M  0.467
1993 Bourgoin S, Pohl M, Mauborgne A, Benoliel JJ, Collin E, Hamon M, Cesselin F. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices. Neuropharmacology. 32: 633-640. PMID 7689707 DOI: 10.1016/0028-3908(93)90076-F  0.407
1993 Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 453-63. PMID 7686633 DOI: 10.1007/Bf00166735  0.431
1993 Emerit MB, Riad M, Fattaccini CM, Hamon M. Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P Journal of Neurochemistry. 60: 2059-2067. PMID 7684066 DOI: 10.1111/j.1471-4159.1993.tb03490.x  0.447
1993 Miquel M-, Emerit MB, Gingrich JA, Gozlan H, Hamon M. 22 - Solubilization and Physicochemical Characterization of 5-HT3 Receptor-Binding Sites Methods in Neurosciences. 11: 375-397. DOI: 10.1016/B978-0-12-185271-9.50027-7  0.438
1993 Mestikawy SE, Emerit MB, Miquel MC, Gozlan H, Hamon M. Pharmacological and biochemical properties of central 5-HT3 and 5-HT4 receptors European Neuropsychopharmacology. 3: 245-246. DOI: 10.1016/0924-977X(93)90053-O  0.437
1992 Pohl M, Collin E, Benoliel JJ, Bourgoin S, Cesselin F, Hamon M. Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment. Neuropeptides. 21: 193-200. PMID 1630603 DOI: 10.1016/0143-4179(92)90044-W  0.308
1992 Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, Göthert M. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. British Journal of Pharmacology. 105: 732-8. PMID 1628159 DOI: 10.1111/J.1476-5381.1992.Tb09047.X  0.477
1992 Kidd E, Bouchelet de Vendegies I, Levy JC, Hamon M, Gozlan H. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system. European Journal of Pharmacology. 211: 133-6. PMID 1618262 DOI: 10.1016/0014-2999(92)90276-A  0.338
1992 Collin E, Bourgoin S, Mantelet S, Hamon M, Cesselin F. Feedback inhibition of met-enkephalin release from the rat spinal cord in vivo. Synapse. 11: 76-84. PMID 1604425 DOI: 10.1002/Syn.890110110  0.335
1992 Laporte AM, Koscielniak T, Ponchant M, Vergé D, Hamon M, Gozlan H. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse (New York, N.Y.). 10: 271-81. PMID 1585260 DOI: 10.1002/Syn.890100402  0.469
1992 Radja F, Daval G, Hamon M, Vergé D. Pharmacological and physicochemical properties of pre-versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study. Journal of Neurochemistry. 58: 1338-1346. PMID 1548468 DOI: 10.1111/J.1471-4159.1992.Tb11347.X  0.365
1992 Matthiessen L, Daval G, Bailly Y, Gozlan H, Hamon M, Vergé D. Quantification of 5-hydroxytryptamine1A receptors in the cerebellum of normal and X-irradiated rats during postnatal development. Neuroscience. 51: 475-85. PMID 1465205 DOI: 10.1016/0306-4522(92)90331-U  0.348
1992 Adrien J, Tissier MH, Lanfumey L, Haj-Dahmane S, Jolas T, Franc B, Hamon M. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat. Neuropharmacology. 31: 519-29. PMID 1407392 DOI: 10.1016/0028-3908(92)90183-P  0.439
1992 Bourgoin S, Pohl M, Benoliel JJ, Mauborgne A, Collin E, Hamon M, Cesselin F. γ-Aminobutyric acid, through GABAA receptors, inhibits the potassium-stimulated release of calcitonin gene-related peptide-but not that of substance P-like material from rat spinal cord slices Brain Research. 583: 344-348. PMID 1380400 DOI: 10.1016/S0006-8993(10)80048-4  0.332
1992 Emerit MB, Riad M, Hamon M. Trophic effects of neurotransmitters during brain maturation Neonatology. 62: 193-201. PMID 1358226 DOI: 10.1159/000243872  0.381
1992 Metzenauer P, Barnes NM, Costall B, Gozlan H, Hamon M, Kelly ME, Murphy DA, Naylor RJ. Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm. Neuroreport. 3: 527-9. PMID 1356500 DOI: 10.1097/00001756-199206000-00019  0.324
1992 Merahi N, Orer HS, Laporte AM, Gozlan H, Hamon M, Laguzzi R. Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat. Neuroscience. 46: 91-100. PMID 1350667 DOI: 10.1016/0306-4522(92)90011-P  0.413
1992 Benoliel JJ, Bourgoin S, Mauborgne A, Pohl M, Legrand JC, Hamon M, Cesselin F. GABA, acting at both GABAA and GABAB receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro Brain Research. 590: 255-262. PMID 1330214 DOI: 10.1016/0006-8993(92)91103-L  0.366
1992 Miquel MC, Doucet E, Riad M, Adrien J, Vergé D, Hamon M. Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain. Brain Research. Molecular Brain Research. 14: 357-62. PMID 1326699 DOI: 10.1016/0169-328X(92)90104-J  0.419
1992 Collin E, Bourgoin S, Ferhat L, Hamon M, Cesselin F. к-Opioid receptor stimulation abolishes μ- but not δ-mediated inhibitory control of spinal Met-enkephalin release Neuroscience Letters. 134: 238-242. PMID 1317026 DOI: 10.1016/0304-3940(92)90525-C  0.367
1992 Benoliel JJ, Mauborgne A, Bourgoin S, Legrand JC, Hamon M, Cesselin F. Opioid Control of the In Vitro Release of Cholecystokinin-Like Material from the Rat Substantia Nigra Journal of Neurochemistry. 58: 916-922. PMID 1310726 DOI: 10.1111/J.1471-4159.1992.Tb09344.X  0.321
1992 Collin E, Mauborgne A, Bourgoin S, Mantelet S, Ferhat L, Hamon M, Cesselin F. KAPPA-/MU-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord Neuroscience. 51: 347-355. PMID 1281527 DOI: 10.1016/0306-4522(92)90319-W  0.366
1991 Radja F, Laporte AM, Daval G, Vergé D, Gozlan H, Hamon M. Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochemistry International. 18: 1-15. PMID 20504669 DOI: 10.1016/0197-0186(91)90029-D  0.439
1991 Miquel MC, Emerit MB, Gozlan H, Hamon M. Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells. Biochemical Pharmacology. 42: 1453-61. PMID 1930269 DOI: 10.1016/0006-2952(91)90459-I  0.447
1991 Emerit MB, Miquel MC, Gozlan H, Hamon M. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor. Journal of Neurochemistry. 56: 1705-16. PMID 1826520 DOI: 10.1111/J.1471-4159.1991.Tb02071.X  0.324
1991 Bing Z, Cesselin F, Bourgoin S, Clot AM, Hamon M, Le Bars D. Acupuncture-like stimulation induces a heterosegmental release of Met-enkephalin-like material in the rat spinal cord. Pain. 47: 71-7. PMID 1771094 DOI: 10.1016/0304-3959(91)90013-N  0.321
1991 Collin E, Mauborgne A, Bourgoin S, Chantrel D, Hamon M, Cesselin F. In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at δ receptors Neuroscience. 44: 725-731. PMID 1721687 DOI: 10.1016/0306-4522(91)90091-2  0.337
1991 Haj-Dahmane S, Hamon M, Lanfumey L. K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience. 41: 495-505. PMID 1714550 DOI: 10.1016/0306-4522(91)90344-N  0.322
1991 Fattaccini CM, Gozlan H, Hamon M. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Neuropharmacology. 30: 15-23. PMID 1710793 DOI: 10.1016/0028-3908(91)90037-C  0.387
1991 Laporte AM, Schechter LE, Bolaños FJ, Vergé D, Hamon M, Gozlan H. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies. European Journal of Pharmacology. 198: 59-67. PMID 1680714 DOI: 10.1016/0014-2999(91)90562-5  0.33
1991 De Vitry F, Hillion J, Catelon J, Thibault J, Benoliel JJ, Hamon M. Dopamine increases the expression of tyrosine hydroxylase and aromatic amino acid decarboxylase in primary cultures of fetal neurons. Brain Research. Developmental Brain Research. 59: 123-31. PMID 1680579 DOI: 10.1016/0165-3806(91)90092-W  0.343
1991 Benoliel JJ, Bourgoin S, Mauborgne A, Legrand JC, Hamon M, Cesselin F. Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation Neuroscience Letters. 124: 204-207. PMID 1648690 DOI: 10.1016/0304-3940(91)90094-A  0.314
1991 Miquel MC, Doucet E, Boni C, El Mestikawy S, Matthiessen L, Daval G, Verge D, Hamon M. Central serotonin1A receptors: Respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain Neurochemistry International. 19: 453-465. DOI: 10.1016/0197-0186(91)90063-J  0.662
1991 Verge D, Matthiessen L, Daval G, Bailly Y, Kia HK, Hamon M. Localization of 5-HT1A serotonin receptors in the cerebellum of young rats Neurochemistry International. 19: 425-431. DOI: 10.1016/0197-0186(91)90059-M  0.455
1991 Riad M, Mestikawy SE, Verge D, Gozlan H, Hamon M. Visualization and quantification of central 5-HT1A receptors with specific antibodies Neurochemistry International. 19: 413-423. DOI: 10.1016/0197-0186(91)90058-L  0.413
1991 Ponchant M, Koscielniak T, Hamon M, Gozlan H. Synthesis of 5-[125I]-iodo-zacopride, a new probe for 5-HT3 receptor binding sites Journal of Labelled Compounds and Radiopharmaceuticals. 29: 1147-1155. DOI: 10.1002/Jlcr.2580291007  0.39
1990 Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M. Direct Immunohistochemical Evidence of the Existence of 5-HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei. The European Journal of Neuroscience. 2: 1144-1154. PMID 12106075 DOI: 10.1111/J.1460-9568.1990.Tb00026.X  0.653
1990 Bourgoin S, Bars DL, Clot AM, Hamon M, Cesselin F. Subcutaneous formalin induces a segmental release of Met-enkephalin-like material from the rat spinal cord. Pain. 41: 323-329. PMID 2388769 DOI: 10.1016/0304-3959(90)90009-3  0.323
1990 Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, el Mestikawy S, Hamon M. Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiology of Aging. 11: 437-49. PMID 2381503 DOI: 10.1016/0197-4580(90)90011-N  0.678
1990 Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolaños F, Schechter L. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Annals of the New York Academy of Sciences. 600: 114-29; discussion 1. PMID 2252305 DOI: 10.1111/J.1749-6632.1990.Tb16877.X  0.619
1990 Miquel MC, Emerit MB, Bolaños FJ, Schechter LE, Gozlan H, Hamon M. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells. Journal of Neurochemistry. 55: 1526-36. PMID 2213008 DOI: 10.1111/J.1471-4159.1990.Tb04935.X  0.37
1990 el Mestikawy S, Riad M, Laporte AM, Vergé D, Daval G, Gozlan H, Hamon M. Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neuroscience Letters. 118: 189-92. PMID 2148816 DOI: 10.1016/0304-3940(90)90623-H  0.637
1990 Martin P, Beninger RJ, Hamon M, Puech AJ. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behavioural Brain Research. 38: 135-44. PMID 2141988 DOI: 10.1016/0166-4328(90)90011-3  0.44
1990 Emerit MB, el Mestikawy S, Gozlan H, Rouot B, Hamon M. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. Biochemical Pharmacology. 39: 7-18. PMID 2136995 DOI: 10.1016/0006-2952(90)90642-X  0.589
1990 Fattaccini CM, Bolaños-Jimenez F, Gozlan H, Hamon M. Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology. 29: 1-8. PMID 1689469 DOI: 10.1016/0028-3908(90)90076-4  0.437
1990 Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M. Direct immunohistochemical evidence of the existence of 5-HT(1A) autoreceptors on serotoninergic neurons in the midbrain raphe nuclei European Journal of Neuroscience. 2: 1144-1154. DOI: 10.1111/j.1460-9568.1990.tb00026.x  0.617
1989 Hamon M, Gallissot MC, Menard F, Gozlan H, Bourgoin S, Vergé D. 5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. European Journal of Pharmacology. 164: 315-22. PMID 2759179 DOI: 10.1016/0014-2999(89)90472-X  0.413
1989 Hoyer D, Gozlan H, Bolanos F, Schechter LE, Hamon M. Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact? European Journal of Pharmacology. 171: 137-9. PMID 2612568 DOI: 10.1016/0014-2999(89)90438-X  0.376
1989 Collin E, Bourgoin S, Gorce P, Hamon M, Cesselin F. Intrathecal porcine calcitonin enhances the release of [Met5]enkephalin-like material from the rat spinal cord European Journal of Pharmacology. 168: 201-208. PMID 2606149 DOI: 10.1016/0014-2999(89)90566-9  0.325
1989 Pohl M, Lombard MC, Bourgoin S, Carayon A, Benoliel JJ, Mauborgne A, Besson JM, Hamon M, Cesselin F. Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord Neuropeptides. 14: 151-159. PMID 2559354 DOI: 10.1016/0143-4179(89)90039-5  0.316
1989 Gozlan H, Schechter LE, Bolanos F, Emerit MB, Miquel MC, Nielsen M, Hamon M. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation. European Journal of Pharmacology. 172: 497-500. PMID 2533081 DOI: 10.1016/0922-4106(89)90033-3  0.437
1989 Radja F, Daval G, Emerit MB, Gallissot MC, Hamon M, Vergé D. Selective irreversible blockade of 5-hydroxytryptamine1A and 5-hydroxytryptamine1C receptor binding sites in the rat brain by 8-MeO-′2-chloro-pat: A quantitative autoradiographic study Neuroscience. 31: 723-733. PMID 2531850 DOI: 10.1016/0306-4522(89)90436-3  0.369
1988 Bourgoin S, Bars DL, Clot AM, Hamon M, Cesselin F. Spontaneous and evoked release of met-enkephalin-like material from the spinal cord of arthritic rats in vivo. Pain. 32: 107-114. PMID 3340418 DOI: 10.1016/0304-3959(88)90029-2  0.324
1988 el Mestikawy S, Cognard C, Gozlan H, Hamon M. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS). Journal of Neurochemistry. 51: 1031-40. PMID 2971097 DOI: 10.1111/J.1471-4159.1988.Tb03064.X  0.613
1988 Hamon M, Bourgoin S, Bars DL, Cesselin F. Chapter 32 In vivo and in vitro release of central neurotransmitters in relation to pain and analgesia Progress in Brain Research. 77: 431-444. PMID 2905819 DOI: 10.1016/S0079-6123(08)62807-1  0.368
1988 Scherman D, Hamon M, Gozlan H, Henry JP, Lesage A, Masson M, Rumigny JF. Molecular pharmacology of niaprazine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 989-1001. PMID 2853885 DOI: 10.1016/0278-5846(88)90093-0  0.417
1988 Bourgoin S, Pohl M, Hirsch M, Mauborgne A, Cesselin F, Hamon M. Direct stimulatory effect of calcitonin on [3H]5-hydroxytryptamine release from the rat spinal cord European Journal of Pharmacology. 156: 13-23. PMID 2463177 DOI: 10.1016/0014-2999(88)90142-2  0.414
1988 Spampinato U, Gozlan H, Daval G, Fattaccini CM, Hamon M. Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats. European Journal of Pharmacology. 150: 113-22. PMID 2456939 DOI: 10.1016/0014-2999(88)90756-X  0.408
1988 Hamon M. Recent developments on the search for the endogenous ligand(s) of central benzodiazepine receptors Neurochemistry International. 13: 13-15. DOI: 10.1016/0197-0186(88)90096-4  0.306
1987 Bars DL, Bourgoin S, Clot AM, Hamon M, Cesselin F. Noxious mechanical stimuli increase the release of Met-enkephalin- like material heterosegmentally in the rat spinal cord Brain Research. 402: 188-192. PMID 3828785 DOI: 10.1016/0006-8993(87)91066-3  0.308
1987 Emerit MB, el Mestikawy S, Gozlan H, Cossery JM, Besselievre R, Marquet A, Hamon M. Identification of the 5-HT1A receptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin. Journal of Neurochemistry. 49: 373-80. PMID 3598578 DOI: 10.1111/J.1471-4159.1987.Tb02875.X  0.633
1987 Daval G, Vergé D, Basbaum AI, Bourgoin S, Hamon M. Autoradiographic evidence of serotonin1 binding sites on primary afferent fibres in the dorsal horn of the rat spinal cord. Neuroscience Letters. 83: 71-6. PMID 3441302 DOI: 10.1016/0304-3940(87)90218-7  0.581
1987 Hamon M, Gozlan H, Bourgoin S, Benoliel JJ, Mauborgne A, Taquet H, Cesselin F, Mico JA. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology. 26: 531-9. PMID 3037421 DOI: 10.1016/0028-3908(87)90144-4  0.337
1987 Daval G, Vergé D, Becerril A, Gozlan H, Spampinato U, Hamon M. Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 5: 171-80. PMID 2972174 DOI: 10.1016/0736-5748(87)90027-X  0.389
1987 Cossery JM, Gozlan H, Spampinato U, Perdicakis C, Guillaumet G, Pichat L, Hamon M. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman. European Journal of Pharmacology. 140: 143-55. PMID 2959487 DOI: 10.1016/0014-2999(87)90800-4  0.375
1987 Mauborgne A, Lutz O, Legrand JC, Hamon M, Cesselin F. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord. Journal of Neurochemistry. 48: 529-37. PMID 2432185 DOI: 10.1111/j.1471-4159.1987.tb04125.x  0.356
1987 Benoliel JJ, Bourgoin S, Mauborgne A, Hamon M, Cesselin F. Invivo and invitro release of endogenous met-enkephalin, substance P and cholecystokinin from rat brain and spinal cord. Effects of peptidase inhibitors Pain. 30. DOI: 10.1016/0304-3959(87)91551-X  0.304
1986 Soubrie P, Martin P, el Mestikawy S, Thiebot MH, Simon P, Hamon M. The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats. Pharmacology, Biochemistry, and Behavior. 25: 1-6. PMID 3749215 DOI: 10.1016/0091-3057(86)90220-0  0.626
1986 Gozlan H, Emerit MB, Hall MD, Nielsen M, Hamon M. In situ molecular sizes of the various types of 5-HT binding sites in the rat brain. Biochemical Pharmacology. 35: 1891-7. PMID 3718534 DOI: 10.1016/0006-2952(86)90308-4  0.397
1986 Petit F, Hamon M, Fournie-Zaluski MC, Roques BP, Glowinski J. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. European Journal of Pharmacology. 126: 1-9. PMID 3019709 DOI: 10.1016/0014-2999(86)90731-4  0.467
1986 Hall MD, Gozlan H, Emerit MB, el Mestikawy S, Pichat L, Hamon M. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Neurochemical Research. 11: 891-912. PMID 3016581 DOI: 10.1007/Bf00965212  0.641
1986 Emerit MB, Gozlan H, Marquet A, Hamon M. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT. European Journal of Pharmacology. 127: 67-81. PMID 2944752 DOI: 10.1016/0014-2999(86)90207-4  0.422
1986 el Mestikawy S, Hamon M. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals? Journal of Neurochemistry. 47: 1425-33. PMID 2876053 DOI: 10.1111/J.1471-4159.1986.Tb00775.X  0.586
1986 Epelbaum J, Lamour Y, Enjalbert A, Hamon M, Dutar P, Kordon C. Modifications in the cortical regional distribution of choline acetyltransferase, somatostatin and somatostatin binding sites in the normal rat and following lesion of the nucleus basalis. Brain Research. 371: 376-379. PMID 2870779 DOI: 10.1016/0006-8993(86)90379-3  0.31
1986 Hamon M, Cossery JM, Spampinato U, Gozlan H. Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? Trends in Pharmacological Sciences. 7: 336-338. DOI: 10.1016/0165-6147(86)90377-9  0.315
1985 Bourgoin S, Artaud F, Cesselin F, Glowinski J, Hamon M. Local and remote effects of intra-caudate administration of GABA-related drugs on Met-enkephalin release in the basal ganglia. Brain Research. 361: 361-72. PMID 3936593 DOI: 10.1016/0006-8993(85)91306-X  0.476
1984 Marcinkiewicz M, Vergé D, Gozlan H, Pichat L, Hamon M. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain Brain Research. 291: 159-163. PMID 6230136 DOI: 10.1016/0006-8993(84)90664-4  0.432
1982 Bourgoin S, Cesselin F, Artaud F, Glowinski J, Hamon M. In vivo modulations by GABA-related drugs of met-enkephalin release in basal ganglia of the cat brain. Brain Research. 248: 321-30. PMID 7139278 DOI: 10.1016/0006-8993(82)90590-X  0.47
1982 El Mestikawy S, Goetz C, Pasquier A, Glowinski J, Hamon M. Long-term local and distal increases in tryptophan hydroxylase activity following intracerebral kainic acid injections in the rat. Brain Research. 244: 319-29. PMID 7116178 DOI: 10.1016/0006-8993(82)90091-9  0.659
1981 Bourgoin S, Cesselin F, Artaud F, Hamon M. Transmitter mechanismIn vitro release of met-enkephalin and 3H-serotonin from the dorsal part of the lumbar cord in rats Pain. 11. DOI: 10.1016/0304-3959(81)90225-6  0.344
1980 Nelson DL, Herbet A, Enjalbert A, Bockaert J, Hamon M. Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I. Biochemical Pharmacology. 29: 2445-53. PMID 7426051 DOI: 10.1016/0006-2952(80)90348-2  0.443
1980 Bourgoin S, Oliveras JL, Bruxelle J, Hamon M, Besson JM. Electrical stimulation of the nucleus raphe magnus in the rat. Effects on 5-HT metabolism in the spinal cord. Brain Research. 194: 377-389. PMID 6155975 DOI: 10.1016/0006-8993(80)91219-6  0.413
1979 Bourgoin S, Adrien J, Laguzzi RF, Dolphin A, Bockaert J, Hery F, Hamon M. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation. Brain Research. 160: 461-78. PMID 421125 DOI: 10.1016/0006-8993(79)91073-4  0.388
1979 Héry F, Simonnet G, Bourgoin S, Soubrié P, Artaud F, Hamon M, Glowinski J. Effect of nerve activity on the in vivo release of [3H]serotonin continuously formed from L-[3H]tryptophan in the caudate nucleus of the cat. Brain Research. 169: 317-34. PMID 221075 DOI: 10.1016/0006-8993(79)91033-3  0.536
1978 Bourgoin S, Artaud F, Bockaert J, Héry F, Glowinski J, Hamon M. Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker. Naunyn-Schmiedeberg's Archives of Pharmacology. 302: 313-21. PMID 662027 DOI: 10.1007/Bf00508301  0.598
1978 Gerschenfeld HM, Hamon M, Paupardin-Tritsch D. Release of endogenous serotonin from two identified serotonin-containing neurones and the physiological role of serotonin re-uptake. The Journal of Physiology. 274: 265-78. PMID 203673 DOI: 10.1113/jphysiol.1978.sp012146  0.306
1977 Lefresne P, Hamon M, Beaujouan JC, Glowinski J. Origin of the acetyl moiety of acetylcholine synthesized in rat striatal synaptosomes. Biochimie. 59: 197-215. PMID 870085 DOI: 10.1016/S0300-9084(77)80291-5  0.352
1977 Bourgoin S, Enjalbert A, Adrien J, Héry F, Hamon M. Midbrain raphe lesion in the newborn rat: II. Biochemical alterations in serotoninergic innervation Brain Research. 127: 111-126. PMID 861745 DOI: 10.1016/0006-8993(77)90383-3  0.431
1977 Ternaux JP, Hery F, Hamon M, Bourgoin S, Glowinski J. 5-HT release from ependymal surface of the caudate nucleus in 'encéphale isolé' cats. Brain Research. 132: 575-9. PMID 303139 DOI: 10.1016/0006-8993(77)90207-4  0.528
1976 Ternaux JP, Boireau A, Bourgoin S, Hamon M, Hery F, Glowinski J. In vivo release of 5-HT in the lateral ventricle of the rat: effects of 5-hydroxytryptophan and tryptophan. Brain Research. 101: 533-48. PMID 1081901 DOI: 10.1016/0006-8993(76)90476-5  0.503
1974 Bauman A, Bourgoin S, Benda P, Glowinski J, Hamon M. Characteristics of tryptophan accumulation by glial cells Brain Research. 66: 253-263. DOI: 10.1016/0006-8993(74)90144-9  0.506
Low-probability matches (unlikely to be authored by this person)
2007 Trigo JM, Renoir T, Lanfumey L, Hamon M, Lesch KP, Robledo P, Maldonado R. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biological Psychiatry. 62: 669-79. PMID 17306775 DOI: 10.1016/j.biopsych.2006.11.005  0.3
2012 Molet J, Bouaziz E, Hamon M, Lanfumey L. Early exposure to ethanol differentially affects ethanol preference at adult age in two inbred mouse strains. Neuropharmacology. 63: 338-48. PMID 22521807 DOI: 10.1016/j.neuropharm.2012.03.028  0.299
1988 Taquet H, Nomoto M, Rose S, Jenner P, Javoy-Agid F, Mauborgne A, Benoliel JJ, Marsden CD, Legrand JC, Agid Y, Hamon M, Cesselin F. Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment. Neuropeptides. 12: 105-110. PMID 2468106 DOI: 10.1016/0143-4179(88)90039-X  0.298
2006 Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology. 189: 59-69. PMID 16969683 DOI: 10.1007/s00213-006-0525-x  0.298
1999 Beaufour CC, Ballon N, Le Bihan C, Hamon M, Thiébot MH. Effects of chronic antidepressants in an operant conflict procedure of anxiety in the rat. Pharmacology, Biochemistry, and Behavior. 62: 591-9. PMID 10208363 DOI: 10.1016/S0091-3057(98)00180-4  0.298
2003 Kayser V, Farré A, Hamon M, Bourgoin S. Effects of the novel analgesic, cizolirtine, in a rat model of neuropathic pain. Pain. 104: 169-77. PMID 12855326 DOI: 10.1016/S0304-3959(02)00497-9  0.297
2004 Gorwood P, Lanfumey L, Hamon M. [Alcohol dependence and polymorphisms of serotonin-related genes]. Mã©Decine Sciences : M/S. 20: 1132-8. PMID 15581469 DOI: 10.1051/medsci/200420121132  0.297
2005 Dubertret C, Hanoun N, Adès J, Hamon M, Gorwood P. Family-based association study of the 5-HT transporter gene and schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 87-92. PMID 15638952 DOI: 10.1017/S1461145704004948  0.297
1995 Charrier D, Dangoumau L, Puech AJ, Hamon M, Thiébot M. Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats. Psychopharmacology. 121: 127-134. PMID 8539337 DOI: 10.1007/Bf02245599  0.296
1987 Taquet H, Javoy-Agid F, Mauborgne A, Benoliel JJ, Agid Y, Legrand JC, Hamon M, Cesselin F. Brain neuropeptides in progressive supranuclear palsy. Brain Research. 411: 178-182. PMID 2440513 DOI: 10.1016/0006-8993(87)90697-4  0.295
1986 Vitry FD, Catelon J, Dubois M, Thibault J, Barritault D, Courty J, Bourgoin S, Hamon M. Partial expression of monoaminergic (serotoninergic) properties by the multipotent hypothalamic cell line F7. An example of learning at the cellular level. Neurochemistry International. 9: 43-53. PMID 20493099 DOI: 10.1016/0197-0186(86)90030-6  0.295
2005 Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, Simonneau G, Hamon M, Adnot S, Eddahibi S. Serotonin transporter and receptors in various forms of human pulmonary hypertension. Chest. 128: 552S-553S. PMID 16373820 DOI: 10.1378/chest.128.6_suppl.552S  0.295
2006 Ahnaou A, Yon L, Arluison M, Vaudry H, Hannibal J, Hamon M, Adrien J, Bourgin P. Immunocytochemical distribution of VIP and PACAP in the rat brain stem: implications for REM sleep physiology. Annals of the New York Academy of Sciences. 1070: 135-42. PMID 16888155 DOI: 10.1196/Annals.1317.095  0.294
2008 Latrémolière A, Mauborgne A, Masson J, Bourgoin S, Kayser V, Hamon M, Pohl M. Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8489-501. PMID 18716207 DOI: 10.1523/JNEUROSCI.2552-08.2008  0.293
2011 Fabre V, Massart R, Rachalski A, Jennings K, Brass A, Sharp T, Lesch KP, Lanfumey L, Hamon M. Differential gene expression in mutant mice overexpressing or deficient in the serotonin transporter: a focus on urocortin 1. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 33-44. PMID 21075611 DOI: 10.1016/j.euroneuro.2010.10.004  0.293
1989 Cesselin F, Bourgoin S, Clot AM, Hamon M, Bars DL. Segmental release of Met-enkephalin-like material from the spinal cord of rats, elicited by noxious thermal stimuli. Brain Research. 484: 71-77. PMID 2713703 DOI: 10.1016/0006-8993(89)90349-1  0.292
2006 Loiseau F, Le Bihan C, Hamon M, Thiébot MH. Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 417-28. PMID 16376525 DOI: 10.1016/j.euroneuro.2005.11.007  0.292
1989 Ruiz G, Hamon M, Vergé D. Chronic phenytoin treatment decreases GABAA but not β-adrenoceptors in the cerebellum of young rats European Journal of Pharmacology. 168: 251-255. PMID 2575037 DOI: 10.1016/0014-2999(89)90573-6  0.291
2009 Molet J, Hamon M, Lanfumey L. P.4.10 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in mice European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70100-2  0.291
1989 Pohl M, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F. Neonatal capsaicin treatment abolishes the modulations by opioids of substance P release from rat spinal cord slices. Neuroscience Letters. 96: 102-107. PMID 2467229 DOI: 10.1016/0304-3940(89)90250-4  0.291
1999 Boutrel B, Franc B, Hen R, Hamon M, Adrien J. Key Role of 5-HT1BReceptors in the Regulation of Paradoxical Sleep as Evidenced in 5-HT1BKnock-Out Mice The Journal of Neuroscience. 19: 3204-3212. DOI: 10.1523/Jneurosci.19-08-03204.1999  0.291
1990 Witte PAD, Hamon M, Mauborgne A, Cesselin F, Levy C, Laduron PM. Ethanol and opiate decrease the axonal transport of substance-P like immunoreactive material in rat vagus-nerves. Neuropeptides. 16: 15-20. PMID 1701224 DOI: 10.1016/0143-4179(90)90024-S  0.291
2003 El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M, Costentin J, Adrien J, Vaugeois JM. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proceedings of the National Academy of Sciences of the United States of America. 100: 6227-32. PMID 12732720 DOI: 10.1073/Pnas.1034823100  0.29
1990 Pohl M, Benoliel JJ, Bourgoin S, Lombard MC, Mauborgne A, Taquet H, Carayon A, Besson JM, Cesselin F, Hamon M. Regional Distribution of Calcitonin Gene-Related Peptide-, Substance P-, Cholecystokinin-, Met5-Enkephalin-, and Dynorphin A (1–8)-Like Materials in the Spinal Cord and Dorsal Root Ganglia of Adult Rats: Effects of Dorsal Rhizotomy and Neonatal Capsaicin Journal of Neurochemistry. 55: 1122-1130. PMID 1697886 DOI: 10.1111/J.1471-4159.1990.Tb03114.X  0.289
1992 Taquet H, Plachot JJ, Pohl M, Collin E, Benoliel JJ, Bourgoin S, Mauborgne A, Meunier JC, Cesselin F, Hamon M. Increased calcitonin gene-related peptide- and cholecystokinin-like immunoreactivities in spinal motoneurones after dorsal rhizotomy. Journal of Neural Transmission. 88: 127-141. PMID 1378744 DOI: 10.1007/Bf01244818  0.289
2005 Forget B, Hamon M, Thiébot MH. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology. 181: 722-34. PMID 15986197 DOI: 10.1007/s00213-005-0015-6  0.288
1999 Bourgin P, Ahnaou A, Laporte AM, Hamon M, Adrien J. Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors. Neuroscience. 89: 291-302. PMID 10051236 DOI: 10.1016/S0306-4522(98)00290-5  0.287
2013 Michot B, Bourgoin S, Kayser V, Hamon M. Effects of tapentadol on mechanical hypersensitivity in rats with ligatures of the infraorbital nerve versus the sciatic nerve. European Journal of Pain (London, England). 17: 867-80. PMID 23229959 DOI: 10.1002/j.1532-2149.2012.00259.x  0.286
1987 Bars DL, Bourgoin S, Villanueva L, Clot AM, Hamon M, Cesselin F. Involvement of the dorsolateral funiculi in the spinal release of Met-enkephalin-like material triggered by heterosegmental noxious mechanical stimuli Brain Research. 412: 190-195. PMID 3607456 DOI: 10.1016/0006-8993(87)91460-0  0.285
1991 Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F. Is substance P released from slices of the rat spinal cord inactivated by peptidase(s) distinct from both 'enkephalinase' and 'angiotensin-converting enzyme'? Neuroscience Letters. 123: 221-225. PMID 1709269 DOI: 10.1016/0304-3940(91)90935-M  0.285
1994 Pohl M, Bourgoin S, Collin E, Benoliel JJ, Nevo I, Conrath M, Hamon M, Cesselin F. Proenkephalin A gene expression in dorsal root ganglia of the rat: Modification by a noxious stimulus Regulatory Peptides. 54: 227-228. DOI: 10.1016/0167-0115(94)90473-1  0.285
1980 Arluison M, De La Manche IS, Adrien J, Hamon M, Laguzzi R, Bourgoin S. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. III. Histochemical fluorescence and radioautographic studies of the noradrenaline hyperinnervation in the pons. Brain Research. 198: 285-305. PMID 7407599 DOI: 10.1016/0006-8993(80)90745-3  0.284
2019 Droguerre M, Tsurugizawa T, Duchêne A, Portal B, Guiard BP, Déglon N, Rouach N, Hamon M, Mouthon F, Ciobanu L, Charvériat M. A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain. Scientific Reports. 9: 18292. PMID 31797899 DOI: 10.1038/S41598-019-54858-9  0.283
2003 Duarte C, Biala G, Le Bihan C, Hamon M, Thiébot MH. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats. Psychopharmacology. 166: 19-32. PMID 12525958 DOI: 10.1007/s00213-002-1310-0  0.283
2010 Païzanis E, Renoir T, Lelievre V, Saurini F, Melfort M, Gabriel C, Barden N, Mocaër E, Hamon M, Lanfumey L. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 759-74. PMID 19775499 DOI: 10.1017/S1461145709990514  0.282
2002 Vitalis T, Cases O, Gillies K, Hanoun N, Hamon M, Seif I, Gaspar P, Kind P, Price DJ. Interactions between TrkB signaling and serotonin excess in the developing murine somatosensory cortex: a role in tangential and radial organization of thalamocortical axons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 4987-5000. PMID 12077195 DOI: 10.1523/Jneurosci.22-12-04987.2002  0.282
2007 Bourgoin S, Viguier F, Michot B, Herlyn A, Hamon M, Kayser V. TO19 Ligands des récepteurs 5-HT7 et manifestations comportementales de douleurs neuropathiques chez le rat Douleurs : Evaluation - Diagnostic - Traitement. 8: 75. DOI: 10.1016/S1624-5687(07)73161-X  0.28
1985 Chanez C, Flexor MA, Hamon M. Long lasting effects of intrauterine growth retardation on basal and 5-HT-stimulated Na+/K+-ATPase in the brain of developing rats Neurochemistry International. 7: 319-329. DOI: 10.1016/0197-0186(85)90121-4  0.279
1997 Jebai F, Hanoun N, Hamon M, Thibault J, Peltre G, Gros F, Krieger M. Expression, purification, and characterization of rat aromatic L-amino acid decarboxylase in Escherichia coli. Protein Expression and Purification. 11: 185-94. PMID 9367815 DOI: 10.1006/Prep.1997.0778  0.278
1999 Ahnaou A, Basille M, Gonzalez B, Vaudry H, Hamon M, Adrien J, Bourgin P. Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat. The European Journal of Neuroscience. 11: 4051-8. PMID 10583493 DOI: 10.1046/J.1460-9568.1999.00811.X  0.278
2010 ANZINI M, CAPPELLI A, VOMERO S, GIORGI G, LANGER T, HAMON M, MERAHI N, EMERIT BM, CAGNOTTO A, SKORUPSKA M, MENNINI T, PINTO JC. ChemInform Abstract: Novel, Potent, and Selective 5-HT3 Receptor Antagonists Based on the Arylpiperazine Skeleton: Synthesis, Structure, Biological Activity, and Comparative Molecular Field Analysis Studies. Cheminform. 26: no-no. DOI: 10.1002/CHIN.199545191  0.275
2014 Martin CB, Gassmann M, Chevarin C, Hamon M, Rudolph U, Bettler B, Lanfumey L, Mongeau R. Effect of genetic and pharmacological blockade of GABA receptors on the 5-HT2C receptor function during stress. Journal of Neurochemistry. 131: 566-72. PMID 25113583 DOI: 10.1111/Jnc.12929  0.274
1993 Adrien J, Desfemmes T, Maudhuit C, Hamon M. Effects of two 5-HT1A agonist with anxiolytic properties: S 14506 and S 20499, on sleep-wakefulness regulations in the rat European Neuropsychopharmacology. 3: 370. DOI: 10.1016/0924-977X(93)90157-H  0.274
2004 Aubel B, Kayser V, Mauborgne A, Farré A, Hamon M, Bourgoin S. Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies. Pain. 110: 22-32. PMID 15275748 DOI: 10.1016/j.pain.2004.03.001  0.273
2003 Tordjman S, Carlier M, Cohen D, Cesselin F, Bourgoin S, Colas-Linhart N, Petiet A, Perez-Diaz F, Hamon M, Roubertoux PL. Aggression and the three opioid families (endorphins, enkephalins, and dynorphins) in mice. Behavior Genetics. 33: 529-36. PMID 14574130 DOI: 10.1023/A:1025774716976  0.273
1992 Pohl M, Collin E, Bourgoin S, Clot AM, Hamon M, Cesselin F, Bars DL. In vivo release of calcitonin gene-related peptide-like material from the cervicotrigeminal area in the rat. Effects of electrical and noxious stimulations of the muzzle. Neuroscience. 50: 697-706. PMID 1436511 DOI: 10.1016/0306-4522(92)90458-E  0.272
2013 Hernández-Hernández O, Guiraud-Dogan C, Sicot G, Huguet A, Luilier S, Steidl E, Saenger S, Marciniak E, Obriot H, Chevarin C, Nicole A, Revillod L, Charizanis K, Lee KY, Suzuki Y, ... ... Hamon M, et al. Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour. Brain : a Journal of Neurology. 136: 957-70. PMID 23404338 DOI: 10.1093/Brain/Aws367  0.271
2004 Duarte C, Lefebvre C, Chaperon F, Hamon M, Thiébot MH. Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1903-15. PMID 12915863 DOI: 10.1038/sj.npp.1300276  0.27
2007 Paizanis E, Kelaï S, Renoir T, Hamon M, Lanfumey L. Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulations. Neurochemical Research. 32: 1762-71. PMID 17406979 DOI: 10.1007/s11064-007-9330-0  0.27
2015 Fabre V, Bonnavion P, Hamon M, Bernard J, Adrien J. Les neurones du noyau dorsal de Gudden qui expriment les récepteurs 5-HT1A sont impliqués dans la régulation des états de vigilance MéDecine Du Sommeil. 12: 16. DOI: 10.1016/J.Msom.2015.01.145  0.269
2007 Meunier A, Latrémolière A, Dominguez E, Mauborgne A, Philippe S, Hamon M, Mallet J, Benoliel JJ, Pohl M. Lentiviral-mediated Targeted NF-κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury-induced Neuropathic Pain in the Rat. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 687-697. PMID 28192702 DOI: 10.1038/sj.mt.6300107  0.269
2002 Boutrel B, Monaca C, Hen R, Hamon M, Adrien J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 4686-92. PMID 12040075 DOI: 10.1523/Jneurosci.22-11-04686.2002  0.269
2002 Kipman A, Bruins-Slot L, Boni C, Hanoun N, Adès J, Blot P, Hamon M, Mouren-Siméoni MC, Gorwood P. 5-HT2A gene promoter polymorphism as a modifying rather than a vulnerability factor in anorexia nervosa European Psychiatry. 17: 227-229. PMID 12231269 DOI: 10.1016/S0924-9338(02)00657-0  0.269
1986 De Vitry F, Hamon M, Catelon J, Dubois M, Thibault J. Serotonin initiates and autoamplifies its own synthesis during mouse central nervous system development. Proceedings of the National Academy of Sciences of the United States of America. 83: 8629-33. PMID 2877460 DOI: 10.1073/PNAS.83.22.8629  0.267
2005 Hamdani N, Bonnière M, Adès J, Hamon M, Boni C, Gorwood P. Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics. Neuroscience Letters. 377: 69-74. PMID 15722190 DOI: 10.1016/j.neulet.2004.11.070  0.267
1988 Hamon M. Neuromethods Neurochemistry International. 12: 103-104. DOI: 10.1016/0197-0186(88)90157-X  0.266
1997 Beaufour C, Ballon N, Bihan CL, Hamon M, Thi??bot M. Acute and chronic antidepressants: Effects in conflict models of anxiety in rats Behavioural Pharmacology. 8: 641. DOI: 10.1097/00008877-199711000-00025  0.266
2009 Cesselin F, Bourgoin S, Mauborgne A, Hamon M, Le Bars D. Freezing of enkephalinergic functions by multiple noxious foci: a source of pain sensitization? Plos One. 4: e6874. PMID 19727441 DOI: 10.1371/journal.pone.0006874  0.265
1992 LANFUMEY L, HAJ-DAHMANE S, JOLAS T, HAMON M. ELECTROPHYSIOLOGICAL EVIDENCE FOR THE AGONIST PROPERTIES OF THE NEW POTENTIAL ANXIOLYTIC DRUG E-4424 ON SOMATODENDRITIC 5-HT1A AUTORECEPTORS Behavioural Pharmacology. 3: 23. DOI: 10.1097/00008877-199204001-00066  0.264
1995 Nevo I, Hamon M. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism Neurochemistry International. 26: 305-336. PMID 7633325 DOI: 10.1016/0197-0186(94)00139-L  0.263
1980 Soubrie P, Thiebot MH, Jobert A, Montastruc JL, Hery F, Hamon M. Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats. Brain Research. 189: 505-517. PMID 6102883 DOI: 10.1016/0006-8993(80)90109-2  0.263
1999 Corti O, Sánchez-Capelo A, Colin P, Hanoun N, Hamon M, Mallet J. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 96: 12120-12125. PMID 10518586 DOI: 10.1073/Pnas.96.21.12120  0.263
2005 Forget B, Hamon M, Thi??bot M. B104 DIFFERENTIAL INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE ESTABLISHMENT AND THE SHORT- AND LONG-TERM EXPRESSION OF NICOTINE-INDUCED CONDITIONED PLACE PREFERENCE IN RATS Behavioural Pharmacology. 16: S99. DOI: 10.1097/00008877-200509001-00309  0.262
2018 Chazalon M, Dumas S, Bernard JF, Sahly I, Tronche F, de Kerchove d'Exaerde A, Hamon M, Adrien J, Fabre V, Bonnavion P. The GABAergic Gudden's dorsal tegmental nucleus: A new relay for serotonergic regulation of sleep-wake behavior in the mouse. Neuropharmacology. PMID 29908240 DOI: 10.1016/J.Neuropharm.2018.06.014  0.262
2011 Prediger RD, Rojas-Mayorquin AE, Aguiar AS, Chevarin C, Mongeau R, Hamon M, Lanfumey L, Del Bel E, Muramatsu H, Courty J, Raisman-Vozari R. Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1215-25. PMID 21301897 DOI: 10.1007/s00702-010-0568-3  0.261
2001 Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension Journal of Clinical Investigation. 108: 1141-1150. PMID 11602621 DOI: 10.1172/Jci12805  0.261
1986 Conrath M, Covenas R, Romo R, Cheramy A, Bourgoin S, Hamon M. Distribution of Met-enkephalin immunoreactive fibres in the thalamus of the cat. Neuroscience Letters. 65: 299-303. PMID 3520398 DOI: 10.1016/0304-3940(86)90278-8  0.259
2009 Forget B, Hamon M, Thiébot MH. Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats. Psychopharmacology. 205: 503-15. PMID 19466393 DOI: 10.1007/s00213-009-1559-7  0.259
1996 Bourgin P, Hamon M, Adrien J. Facilitation à long terme du sommeil paradoxal par micro-injection de VIP dans la formation réticulée pontique du rat Neurophysiologie Clinique-Clinical Neurophysiology. 26: 427-428. DOI: 10.1016/S0987-7053(97)89166-6  0.258
1991 Taquet H, Plachot JJ, Collin E, Pohl M, Bourgoin S, Meunier JC, Cesselin F, Hamon M. Increased calcitonin gene-related peptide-like immunoreactivity (CGRPLI) in spinal motoneurones after dorsal rhizotomy Regulatory Peptides. 34: 106. DOI: 10.1016/0167-0115(91)90427-I  0.258
1998 Ahnaou A, Bourgin P, Escourrou P, Hamon M, Adrien J. Induction de sommeil paradoxal par micro-injection de PACAP dans la formation réticulée pontique chez le rat Neurophysiologie Clinique/Clinical Neurophysiology. 28: 155. DOI: 10.1016/S0987-7053(98)80029-4  0.257
2007 Paizanis E, Hamon M, Lanfumey L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plasticity. 2007: 73754. PMID 17641737 DOI: 10.1155/2007/73754  0.256
1989 Ehret M, Cash CD, Hamon M, Maitre M. Formal demonstration of the phosphorylation of rat brain tryptophan hydroxylase by Ca2+/calmodulin-dependent protein kinase Journal of Neurochemistry. 52: 1886-1891. PMID 2542452 DOI: 10.1111/J.1471-4159.1989.Tb07272.X  0.255
2012 Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J, Lesch KP, Lanfumey L, Steinbusch HW, Kenis G. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Molecular Psychiatry. 17: 584-96. PMID 21894152 DOI: 10.1038/mp.2011.107  0.254
1982 Thiébot MH, Hamon M, Soubrié P. Attenuation of induced-anxiety in rats by chlordiazepoxide: Role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons Neuroscience. 7: 2287-2294. PMID 6292786 DOI: 10.1016/0306-4522(82)90139-7  0.254
2005 Guignabert C, Li Z, Hanoune N, Tu L, Raffestin B, Rodman D, Hamon M, Adnot S, Eddahibi S. 107 Mice overexpressing the 5-hydroxytryptamine transporter in smooth muscle cells spontaneously develop pulmonary hypertension Revue Des Maladies Respiratoires. 22: 900. DOI: 10.1016/S0761-8425(05)92519-9  0.253
2020 Vidal B, Droguerre M, Valdebenito M, Zimmer L, Hamon M, Mouthon F, Charvériat M. Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine. Frontiers in Neuroscience. 14: 835. PMID 32903470 DOI: 10.3389/fnins.2020.00835  0.253
1999 Ridet J, Corti O, Pencalet P, Hanoun N, Hamon M, Philippon J, Mallet J. Toward Autologous ex Vivo Gene Therapy for the Central Nervous System with Human Adult Astrocytes Human Gene Therapy. 10: 271-280. PMID 10022551 DOI: 10.1089/10430349950019057  0.252
2006 Dewachter L, Adnot S, Fadel E, Humbert M, Maitre B, Barlier-Mur AM, Simonneau G, Hamon M, Naeije R, Eddahibi S. Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. 174: 1025-33. PMID 16917117 DOI: 10.1164/rccm.200602-304OC  0.252
1981 Chanez C, Priam M, Flexor MA, Hamon M, Bourgoin S, Kordon C, Minkowski A. Long lasting effects of intrauterine growth retardation of 5-HT metabolism in the brain of developing rats. Brain Research. 207: 397-408. PMID 6162525 DOI: 10.1016/0006-8993(81)90372-3  0.25
1988 Taquet H, Javoy-Agid F, Mauborgne A, Benoliel JJ, Agid Y, Legrand JC, Tramu G, Cesselin F, Hamon M. Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex. Neuroscience. 27: 871-883. PMID 2472575 DOI: 10.1016/0306-4522(88)90190-X  0.25
1977 Adrien J, Bourgoin S, Hamon M. Midbrain raphe lesion in the newborn rat. I. Neurophysiological aspects of sleep Brain Research. 127: 99-110. PMID 861756 DOI: 10.1016/0006-8993(77)90382-1  0.25
2012 Yacoubi ME, Popa D, Martin B, Zimmer L, Hamon M, Adrien J, Vaugeois JM. Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 363-74. PMID 21557882 DOI: 10.1017/S1461145711000605  0.249
2006 Popa D, El Yacoubi M, Vaugeois JM, Hamon M, Adrien J. Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1637-46. PMID 16292325 DOI: 10.1038/Sj.Npp.1300948  0.247
2009 Fournier M, Vitte J, Garrigue J, Langui D, Dullin JP, Saurini F, Hanoun N, Perez-Diaz F, Cornilleau F, Joubert C, Ardila-Osorio H, Traver S, Duchateau R, Goujet-Zalc C, Paleologou K, ... ... Hamon M, et al. Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy. Plos One. 4: e6629. PMID 19680561 DOI: 10.1371/Journal.Pone.0006629  0.245
2004 Dubertret C, Gouya L, Hanoun N, Deybach J, Adès J, Hamon M, Gorwood P. The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia Schizophrenia Research. 67: 75-85. PMID 14741327 DOI: 10.1016/S0920-9964(03)00220-2  0.244
2010 Prediger RD, Aguiar AS, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R. Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease. Neurotoxicity Research. 17: 114-29. PMID 19629612 DOI: 10.1007/s12640-009-9087-0  0.243
2004 Chaouat A, Eddahibi S, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, Adnot S. 19 Polymorphisme du transporteur de la serotonine et hypertension pulmonaire dans la BPCO Revue Des Maladies Respiratoires. 21: 15-15. DOI: 10.1016/S0761-8425(04)71645-9  0.243
2020 Droguerre M, Duchêne A, Picoli C, Portal B, Lejards C, Guiard BP, Meunier J, Villard V, Déglon N, Hamon M, Mouthon F, Charvériat M. Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer's Disease. Frontiers in Neuroscience. 14: 563. PMID 32612499 DOI: 10.3389/fnins.2020.00563  0.242
2006 Kayser V, Farré A, Buschmann H, Hamon M, Bourgoin S. 319 EFFECTS OF AMITRIPTYLINE, GABAPENTIN OR THEIR COMBINATION ON PAIN-RELATED BEHAVIOURS IN TWO RAT MODELS OF CEPHALIC AND EXTRA-CEPHALIC NEUROPATHIC PAIN European Journal of Pain. 10: S85b-S85. DOI: 10.1016/S1090-3801(06)60322-4  0.242
2004 Brouri F, Hanoun N, Mediani O, Saurini F, Hamon M, Vanhoutte PM, Lechat P. Blockade of β1- and desensitization of β2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis European Journal of Pharmacology. 485: 227-234. PMID 14757145 DOI: 10.1016/J.Ejphar.2003.11.063  0.242
2003 Gorwood P, Limosin F, Batel P, Hamon M, Adès J, Boni C. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biological Psychiatry. 53: 85-92. PMID 12513948 DOI: 10.1016/S0006-3223(02)01440-3  0.241
2003 Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, Adnot S. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation. 108: 1839-44. PMID 14530202 DOI: 10.1161/01.CIR.0000091409.53101.E8  0.241
2013 Lanfumey L, Mongeau R, Hamon M. Biological rhythms and melatonin in mood disorders and their treatments. Pharmacology & Therapeutics. 138: 176-84. PMID 23348014 DOI: 10.1016/j.pharmthera.2013.01.005  0.238
2002 Brouri F, Findji L, Mediani O, Mougenot N, Hanoun N, Naour GL, Hamon M, Lechat P. Toxic cardiac effects of catecholamines: role of β-adrenoceptor downregulation European Journal of Pharmacology. 456: 69-75. PMID 12450571 DOI: 10.1016/S0014-2999(02)02643-2  0.238
1997 Bourgin P, Lebrand C, Escourrou P, Gaultier C, Franc B, Hamon M, Adrien J. Vasoactive intestinal polypeptide microinjections into the oral pontine tegmentum enhance rapid eye movement sleep in the rat. Neuroscience. 77: 351-60. PMID 9472395 DOI: 10.1016/S0306-4522(96)00455-1  0.238
1981 Oliveras JL, Cesselin F, Bourgoin S, Sierralta F, Besson JM, Hamon M. Increased release of met-enkephalin-like material (MELM) in the CSF of anaesthesized cats after tooth pulp stimulation Pain. 11. DOI: 10.1016/0304-3959(81)90226-8  0.235
2008 Hamdani N, Tabeze JP, Ramoz N, Ades J, Hamon M, Sarfati Y, Boni C, Gorwood P. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 34-40. PMID 17669634 DOI: 10.1016/j.euroneuro.2007.05.005  0.235
2000 Gorwood P, Batel P, Adès J, Hamon M, Boni C. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biological Psychiatry. 48: 259-64. PMID 10960156 DOI: 10.1016/S0006-3223(00)00840-4  0.234
2009 Michot B, Bourgoin S, Bouzian N, Hamon M, Kayser V. 390 NARATRIPTAN DIFFERENTIALLY ALLEVIATES OXALIPLATIN-INDUCED NEUROPATHIC PAIN IN CEPHALIC VERSUS EXTRACEPHALIC TERRITORIES IN MICE European Journal of Pain. 13: S117b-S117. DOI: 10.1016/S1090-3801(09)60393-1  0.233
2007 Izikki M, Hanoun N, Marcos E, Savale L, Barlier-Mur A, Saurini F, Eddahibi S, Hamon M, Adnot S. 084 Deficiency in Tryptophan Hydroxylase 1 (TPH1) gene or C1473G Polymorphism of the TPH2 Gene Alter Development of Hypoxic Pulmonary Hypertension in Mice Revue Des Maladies Respiratoires. 24: 1234. DOI: 10.1016/S0761-8425(07)74375-9  0.233
2013 Molet J, Hervé D, Thiébot MH, Hamon M, Lanfumey L. Juvenile ethanol exposure increases rewarding properties of cocaine and morphine in adult DBA/2J mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1816-25. PMID 23619165 DOI: 10.1016/j.euroneuro.2013.03.010  0.233
2007 Sevoz-Couche C, Hamon M, Bernard JF, Laguzzi R. S.23.01 Cardiovascular reflexes: physiological and pathophysiological influences from the brain European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70265-1  0.231
2008 Lanfumey L, Kelai S, Hamon M. Mouse strain related effects of cannabinoid and serotonergic ligands on alcohol appetence European Psychiatry. 23: S41. DOI: 10.1016/j.eurpsy.2008.01.150  0.23
2015 Martin CB, Martin VS, Trigo JM, Chevarin C, Maldonado R, Fink LH, Cunningham KA, Hamon M, Lanfumey L, Mongeau R. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522398 DOI: 10.1093/Ijnp/Pyu056  0.229
1988 Pohl M, Carayon A, Cesselin F, Hamon M. Angiotensin II-like material extracted from the rat brain is distinct from authentic angiotensin II Journal of Neurochemistry. 51: 1407-1413. PMID 3171586 DOI: 10.1111/J.1471-4159.1988.Tb01105.X  0.227
2004 Limosin F, Loze JY, Boni C, Fedeli LP, Hamon M, Rouillon F, Adès J, Gorwood P. The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neuroscience Letters. 362: 91-4. PMID 15193761 DOI: 10.1016/j.neulet.2004.02.065  0.226
2009 Ramoz N, Boni C, Downing AM, Close SL, Peters SL, Prokop AM, Allen AJ, Hamon M, Purper-Ouakil D, Gorwood P. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2135-42. PMID 19387424 DOI: 10.1038/npp.2009.39  0.224
2008 Alexandre C, Dordal A, Aixendri R, Guzman A, Hamon M, Adrien J. Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice. Sleep. 31: 259-70. PMID 18274274 DOI: 10.1093/Sleep/31.2.259  0.223
2009 Kayser V, Melfort M, Hamon M, Masson J, Bourgoin S. 323 HYPOSENSITIVITY TO NOXIOUS STIMULI AND INCREASED RESPONSE TO MORPHINE IN GLUTAMINASE-DEFICIENT MICE European Journal of Pain. 13: S99-S99. DOI: 10.1016/S1090-3801(09)60326-8  0.223
2009 Pichard C, Gorwood PA, Hamon M, Cohen-Salmon C. Differential effects of free versus imposed motor activity on alcohol consumption in C57BL/6J versus DBA/2J mice. Alcohol (Fayetteville, N.Y.). 43: 593-601. PMID 20004337 DOI: 10.1016/j.alcohol.2009.10.007  0.221
2007 Kayser V, Michot B, Hamon M, Bourgoin S. TO18 Blocage/activation des récepteurs du CGRP et 5-HT1B/1D de la sérotonine et manifestations comportementales d’allodynie/hyperalgésie chez le rat neuropathique Douleurs : Evaluation - Diagnostic - Traitement. 8: 74-75. DOI: 10.1016/S1624-5687(07)73160-8  0.221
2008 Hamon M, Kayser V, Bourgoin S. [Neuropathic pain. Physiopathological mechanisms and therapeutic perspectives]. Bulletin De L'Acadã©Mie Nationale De Mã©Decine. 192: 921-6; discussion 92. PMID 19238782  0.217
2004 Becker C, Andre J, Zeau B, Rettori MC, Guardiola-Lemaitre B, Hamon M, Benoliel JJ. Melatonin MT receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat. Neuropharmacology. 46: 1158-1167. PMID 32585788 DOI: 10.1016/j.neuropharm.2004.02.006  0.212
1998 Boutrel B, Hamon M, Adrien J. Étude des états de vigilance chez la sourisn'exprimant pas le récepteur 5-HT1B. Effets de ligands 5-HT1A et 5-HT1B Neurophysiologie Clinique/Clinical Neurophysiology. 28: 157. DOI: 10.1016/S0987-7053(98)80033-6  0.212
2017 Bourgoin S, Gautier A, Hamon M. Le yin et le yang de la sérotonine : un Janus dans les contrôles de la douleur Douleur Et Analgesie. 30: 35-56. DOI: 10.1007/S11724-017-0486-3  0.212
2002 Hamon M. Mécanismes neurobiologiques de la dépendance : implication de la sérotonine Bulletin De L Academie Nationale De Medecine. 186: 307-317. DOI: 10.1016/S0001-4079(19)34337-7  0.21
1989 Hamon M. Chloride Channels and their Modulation by Neurotransmitters and Drugs—Advances in Biochemical Psychopharmacology Neurochemistry International. 15: 374. DOI: 10.1016/0197-0186(89)90151-4  0.208
2014 Hamon M. Bases neurobiologiques des traitements de l’alcoolo-dépendance – Quelles perspectives ? European Psychiatry. 29: 539-539. DOI: 10.1016/J.EURPSY.2014.09.411  0.205
2012 Martin C, Chevarin C, Gassman M, Hamon M, Bettler B, Lanfumey L, Mongeau R. Contrôle GABAergique du tonus sérotoninergique central — rôle des récepteurs GABAB et implication possible dans l’action antidépressive de la kétamine L'EncéPhale. 38: S5. DOI: 10.1016/J.Encep.2012.06.026  0.205
2004 Forget B, Hamon M, Thiebot M. P27 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE INCENTIVE VALUE OF NICOTINE Behavioural Pharmacology. 15: A16. DOI: 10.1097/00008877-200409000-00067  0.204
2012 Jeanson T, Figueiredo A, Mouthon F, Charvériat M, Bourgoin S, Hamon M. Potentialisation de l’action anti-hyperalgésique de l’amitriptyline par inhibition des connexines chez le rat porteur de ligatures sur le nerf sciatique Douleurs : Evaluation - Diagnostic - Traitement. 13: A97. DOI: 10.1016/j.douler.2012.08.266  0.202
2005 Yacoubi ME, Popa D, Martin B, Hamon M, Costentin J, Adrien J, Vaugeois J-. P.2.11 Crossbreeding studies with helpless “HIRouen” and “NH/Rouen” indicate that some phenotypic differences between the lines are related to the helpless trait European Neuropsychopharmacology. 15. DOI: 10.1016/S0924-977X(05)80151-8  0.199
2015 Hamon M. La douleur pour les nuls European Psychiatry. 30: S1-S1. DOI: 10.1016/J.EURPSY.2015.09.014  0.197
1992 Ben-Ari Y, Volpe JJ, Greisen G, Levene M, Saliba E, Autret E, Nasr C, Sue AL, Laugier J, Maršál K, Ley D, Emerit MB, Riad M, Hamon M, Raju TNK, et al. International Symposium on Fetal and Neonatal Neurology Neonatology. 62: 295-307. DOI: 10.1159/000243885  0.195
1989 Taquet H, Javoy-Agid F, Mauborgne A, Benohel J, Agid Y, Cesselin F, Hamon M. Neuropeptides in the basal ganglia of patients with Parkinson's or Steele-Richardson's disease Acta Neurologica Scandinavica. 79: 267-267. DOI: 10.1111/j.1600-0404.1989.tb03778.x  0.195
2005 Limosin F, Loze JY, Boni C, Hamon M, Adès J, Rouillon F, Gorwood P. Male-specific association between the 5-HTTLPR S allele and suicide attempts in alcohol-dependent subjects. Journal of Psychiatric Research. 39: 179-82. PMID 15589566 DOI: 10.1016/j.jpsychires.2004.06.007  0.195
1994 Hamon M. Neuropharmacology of anxiety: perspectives and prospects Trends in Pharmacological Sciences. 15: 36-39. PMID 7909396 DOI: 10.1016/0165-6147(94)90104-X  0.194
2010 Llorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, Baylé F, Hamon M, Lançon C, Thibaut F, Thomas P, Lancrenon S, Guillaume S, Samalin L. [Screening and management of bipolar disorders: results]. L'Encã©Phale. 36: S86-102. PMID 21185427 DOI: 10.1016/S0013-7006(10)70037-3  0.194
1983 Hamon M, Soubrié P. Searching for endogenous ligand(s) of central benzodiazepine receptors Neurochemistry International. 5: 663-672. DOI: 10.1016/0197-0186(83)90090-6  0.194
2010 Belhadj-Tahar H, Sadeg N, Richecoeur J, Frances B, Hamon M. [Clinical and neuro-physiopathological effects of an olanzapine overdose]. Thã©Rapie. 65: 143-5. PMID 20578345 DOI: 10.2515/Therapie/2010009  0.193
2003 André J, Becker C, Zeau B, Le Bars D, Hamon M, Cesselin F, Benolil JJ. Relations entre pathologies psychiatriques et douleur: une approche chez l’animal? Douleur Et AnalgéSie. 16: 29-36. DOI: 10.1007/BF03008100  0.193
2017 Goullé J, Morel F, Barthélémy C, Bousser M, Fantoni-Quinton S, Réthoré M, Adès J, Chamoux A, Costentin J, Gonnet C, Hamon M, Hauw J, Lechevalier B, Léger J, Lejoyeux M, et al. Addictions en milieu professionnel Bulletin De L Academie Nationale De Medecine. 201: 941-955. DOI: 10.1016/S0001-4079(19)30391-7  0.193
1983 HAMON M. Neurotransmitter interaction and compartmentationEdited by H. F. Bradford. Published by Plenum Press, New York, 1982. Price $95. ISBN 0-306-41015-X Neurochemistry International. 5: 502-502. DOI: 10.1016/0197-0186(83)90087-6  0.192
2004 Nevo I, Hamon M. NEUROTRANSMITTER AND NEUROMODULATORY MECHANISMS INVOLVED IN ALCOHOL ABUSE AND ALCOHOLISM. Alcoholism: Clinical & Experimental Research. 28: 40A. DOI: 10.1097/00000374-200408002-00203  0.189
2016 Olié J, Légeron P, Acker A, Adolphe M, Allilaire J, Chamoux A, Falissard B, Géraut C, Giudicelli CP, Hamon M, Gall JL, Lôo H, Moussaoui D, Nicolas G, Touitou Y. Le burn-out Bulletin De L Academie Nationale De Medecine. 200: 349-365. DOI: 10.1016/S0001-4079(19)30765-4  0.188
2006 Belhadj-Tahar H, Sadeg N, Burnod A, Hamon M. [Transitory acute psychosis with serotoninergic syndrome at the time of an intoxication by dosulepin associated with doxylamine and ethanol]. Thã©Rapie. 61: 540-3. PMID 17348613 DOI: 10.2515/Therapie:2006080  0.186
Hide low-probability matches.